2010 Annual Meeting | Poster Session 05

Date Thursday 04/15/10

Time 07:30 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Aging and Dementia, Anterior Horn, Behavioral Neurology, Child Neurology/Developmental Neurobiology, Epilepsy, Interventional Neurology, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neural Repair/Rehabilitation, Neurotoxicology, Peripheral Nerve

CME Available No CME available

Event Timeline
07:00 AM - 08:30 AM		Break
07:30 AM - 12:00 PM	Abstract	001 - The Contribution of Neuropsychiatric Symptoms to the Cost of Frontotemporal, Alzheimer and Vascular Dementia Care
07:30 AM - 12:00 PM	Abstract	002 - Subgenual Cingulate Gyrus Deep Brain Stimulation for Refractory Major Depressive Disorder: PET Findings
07:30 AM - 12:00 PM	Abstract	003 - Psychiatric Comorbidities Are Frequent in Patients with Migraine, Epilepsy and Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	004 - The Effectiveness of the One Item Interview Are You Depressed? in Multiple Sclerosis and Hereditary Spastic Paraplegia
07:30 AM - 12:00 PM	Abstract	005 - Structural Brain Differences Associated with Personality
07:30 AM - 12:00 PM	Abstract	006 - Laughter Induction in the NIH OCD DBS Cohort: A Potential Predictor of Therapeutic Response?
07:30 AM - 12:00 PM	Abstract	007 - Traumatic Brain Injuries and Psychogenic Nonepileptic Seizures
07:30 AM - 12:00 PM	Abstract	008 - Tizanidine Improves Geriatric Depression Scale Scores in Stroke and Brain Injury Survivors with Spastic Hemiparesis: Post-Hoc Analysis from a Randomized, Double-Blind, Placebo-Controlled Trial
07:30 AM - 12:00 PM	Abstract	009 - Receptive Aprosodia and the Acquired Loss of Empathy Following Acute Stroke
07:30 AM - 12:00 PM	Abstract	010 - Metacognitive Sensitivity to Neuropsychological Impairment in Frontotemporal Degeneration and Alzheimer's Disease
07:30 AM - 12:00 PM	Abstract	011 - Line Bisection and "Where" Perceptual-Attentional Spatial Bias: Aged Men Go Right
07:30 AM - 12:00 PM	Abstract	012 - Posterior Cortical Atrophy and Cholinesterase Inhibitors: Do They Help?
07:30 AM - 12:00 PM	Abstract	013 - Superior Temporal Sulcus and Detection of Rare Events
07:30 AM - 12:00 PM	Abstract	014 - Drug-Induced Changes in Performance on the Divided Attention Task in Subjects with a History of Recreational Drug Use
07:30 AM - 12:00 PM	Abstract	015 - A Descriptive Study on Constructional Apraxia in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	016 - The Clinical Presentation and Functional Neuroimaging Characteristics of Posterior Cortical Atrophy
07:30 AM - 12:00 PM	Abstract	017 - Late-Life Attention Deficit Hyperactivity Disorder (ADHD): A Neglected Condition in a Memory Clinic
07:30 AM - 12:00 PM	Abstract	018 - Disorders of Higher Cognitive Visual Functions in Pure Alexia
07:30 AM - 12:00 PM	Abstract	019 - The Iowa Gambling Tasks and Its Relation with Fluid Intelligence
07:30 AM - 12:00 PM	Abstract	020 - Armodafinil and Modafinil Counteract the Attentional Dysfunction Associated with Sleep Deprivation: Implications for Treating Parkinson's Dementia and Dementia with Lewy Bodies
07:30 AM - 12:00 PM	Abstract	021 - Effect of Tetrabenazine (TBZ) on Motor Function in Patients with Huntington Disease (HD)
07:30 AM - 12:00 PM	Abstract	022 - Huntington Disease Prevalence in a Cohort from Argentina: Analysis of Normal CAG Repeats in Huntingtin Gene among HD Patients and Control Individuals
07:30 AM - 12:00 PM	Abstract	023 - Interaction of Normal and Mutant CAG Repeat Sizes and Age at Onset in a Huntington Disease Cohort from Argentina
07:30 AM - 12:00 PM	Abstract	024 - Clinical Correlates of Eye Movements in Huntington Disease
07:30 AM - 12:00 PM	Abstract	025 - Impact of Placebo Treatment in Huntington's Disease
07:30 AM - 12:00 PM	Abstract	026 - Evaluation of mGluR5 in Early Parkinson and Huntington Disease Using 18F-FPEB PET Imaging
07:30 AM - 12:00 PM	Abstract	027 - OFF Test for Patients Treated with Globus Pallidus Internus Deep Brain Stimulation for Huntington's Disease
07:30 AM - 12:00 PM	Abstract	028 - Upper Face Chorea in Huntington Disease
07:30 AM - 12:00 PM	Abstract	029 - Impact of Caffeine Intake on Huntington's Disease (HD) Course
07:30 AM - 12:00 PM	Abstract	030 - Increases of 8-Hydroxy-2-Deoxyguanosine Plasma Levels in Patients with Huntington's Disease
07:30 AM - 12:00 PM	Abstract	031 - Rate of Change in Early Huntington's Disease Patients without Antipsychotics
07:30 AM - 12:00 PM	Abstract	032 - Pharmacokinetics of Oral Teriflunomide, a Novel Oral Disease-Modifying Agent under Investigation for the Treatment of Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	033 - Teriflunomide Treatment Reduces Infiltration of Macrophages, T Cells and B Cells, and Increases Survival of Oligodendrocytes in the Spinal Cord of the Dark Agouti Rat Model of Experimental Allergic Encephalomyelitis
07:30 AM - 12:00 PM	Abstract	034 - 25-OH Vitamin D3 Reduces Interferon Gamma and Interleukin-17 Release from CD4+ T-Cells
07:30 AM - 12:00 PM	Abstract	035 - Continuous Down-Regulation of VLA-4 and Accumulation of Natalizumab at the VLA-4 Receptor: Potential Molecular Basis of Enhanced Treatment Efficacy and Occurrence of Opportunistic Infections
07:30 AM - 12:00 PM	Abstract	036 - Long-Term Follow-Up of Immune Thrombocytopenia after Treatment of Multiple Sclerosis Patients with Alemtuzumab in CAMMS223
07:30 AM - 12:00 PM	Abstract	037 - Network Analysis of Transcriptional Regulation in Response to Interferon-[beta]-1a Multiple Sclerosis Treatment Suggests a Molecular Basis for Adverse Effects
07:30 AM - 12:00 PM	Abstract	038 - Oral Fingolimod (FTY720) in Relapsing-Remitting Multiple Sclerosis: Baseline Patient Demographics and Disease Characteristics from a 2-Year Phase III Trial (FREEDOMS II)
07:30 AM - 12:00 PM	Abstract	039 - Serum from Interferon-[beta]-1b Treated MS Patients Induced In Vitro Stabilisation of the Blood-Brain Barrier
07:30 AM - 12:00 PM	Abstract	040 - Pharmacological Changes Induced by Administration of PEGylated IFNb -1a in Healthy Volunteers
07:30 AM - 12:00 PM	Abstract	041 - Persistence of Neutralizing Antibodies Against Interferon Beta in Multiple Sclerosis Patients Switching to Natalizumab
07:30 AM - 12:00 PM	Abstract	042 - Sustained Positive Effects of Alemtuzumab on Diverse Neurological Functions in Relapsing-Remitting Multiple Sclerosis Patients
07:30 AM - 12:00 PM	Abstract	043 - Plasma Exchanges in Severe and Acute Inflammatory Demyelinating Attacks of the Central Nervous System
07:30 AM - 12:00 PM	Abstract	044 - Vitamin D and Cognitive Impairment in Multiple Sclerosis (MS)
07:30 AM - 12:00 PM	Abstract	045 - Effects of Pro-Inflammatory Cytokines on Cannabinoid CB1 and CB2 Receptors in Immune Cells of Normal Subjects and Patients with Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	046 - Morphea in a Multiple Sclerosis Patient Treated with Natalizumab
07:30 AM - 12:00 PM	Abstract	047 - The Kinetics of CSF Lymphocyte Recovery after Cessation of Natalizumab in Patients with Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	048 - Expanded Laboratory Surveillance for PML in a Large Cohort of Patients on Natalizumab for Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	049 - Glatiramer Acetate Reduces Th17 Inflammation and Induces Regulatory T-Cells in the CNS of Mice with Relapsing-Remitting and Chronic Experimental Autoimmune Encephalomyelitis
07:30 AM - 12:00 PM	Abstract	050 - Amelanotic Lentigo Maligna Melanoma Associated with Long-Term Natalizumab Treatment for Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	051 - Rapid Onset of Natalizumab Effect Regardless of Baseline Disease Activity in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	052 - BAF312, a Selective S1P1/S1P5 Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P1 in Mediating a Transient Heart Rate Reduction
07:30 AM - 12:00 PM	Abstract	053 - The Immunoregulatory Properties of Laquinimod on Human B Cells
07:30 AM - 12:00 PM	Abstract	054 - IFNB-1b Therapy Reduces vs. Glatiramer Acetate the Evolution of Permanent T1 Hypointensities ("Black Holes") on Brain MRI in Treatment-Na[iuml]ve RRMS Patients
07:30 AM - 12:00 PM	Abstract	055 - Course of Multiple Sclerosis Associated Fatigue during Treatment with Glatiramer Acetate
07:30 AM - 12:00 PM	Abstract	056 - Time Dependent Ex Vivo RNA Expression Analysis of Monocytes Derived from Glatiramer Acetate Treated Multiple Sclerosis Patients
07:30 AM - 12:00 PM	Abstract	057 - The Influence of Plasma Exchange Treatment on Cellular Immunity in Multiple Sclerosis Relapses Refractory to Steroid Therapy
07:30 AM - 12:00 PM	Abstract	058 - Oral Administration of the Small Molecule Lipoic Acid Leads to Elevation in cAMP Levels in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	059 - Association of Th1/Th2-Related Chemokine Receptors in Peripheral T Cells with Disease Activity and Immunomodulatory Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica
07:30 AM - 12:00 PM	Abstract	060 - Low-Contrast Letter Acuity Detects Visual Function Improvement in Phase 3 Relapsing MS Trials of Natalizumab
07:30 AM - 12:00 PM	Abstract	061 - Long Term Treatment of Multiple Sclerosis with Glatiramer Acetate: Natural History of the Subtypes of Anti-Glatiramer Acetate Antibodies and Their Correlation with Clinical Efficacy
07:30 AM - 12:00 PM	Abstract	062 - A Treatment for Lipoatrophy-Induced Injection with Subcutaneous Glatiramer Acetate
07:30 AM - 12:00 PM	Abstract	063 - Ocular Coherence Tomography in a Three-Year-Old with Neuromyelitis Optica
07:30 AM - 12:00 PM	Abstract	064 - Retinal Nerve Fibre Layer Thickness Is Associated with Cognitive Performance in Youth with Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	065 - Optical Coherence Tomography as a Clinical Trial Outcome Measure: Implications of Treating On-Study Relapses with Intravenous Methylprednisolone
07:30 AM - 12:00 PM	Abstract	066 - Improving Optical Coherence Tomography Sensitivity and Specificity in Multiple Sclerosis by Analysis of Retinal Nerve Fiber Layer Shape
07:30 AM - 12:00 PM	Abstract	067 - Maximizing the Reliability of Serial Stratus OCT Testing in Multiple Sclerosis Patients
07:30 AM - 12:00 PM	Abstract	068 - Retinal Nerve Fiber Layer Thickness Correlates with Gray and White Matter Volume in MS
07:30 AM - 12:00 PM	Abstract	069 - Visual Function in Neuromyelitis Optica: From Retina to Optic Tracts
07:30 AM - 12:00 PM	Abstract	070 - Trend towards Lowering of Multiple Sclerosis Severity Scores among More Recent Enrollees into the New York State Multiple Sclerosis Consortium
07:30 AM - 12:00 PM	Abstract	071 - Comparability of Randomized Controlled Versus Observational Studies: Findings from the Toronto Observational Study of Natalizumab in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	072 - Demographic and Clinical Characteristics of Patients Treated with Natalizumab in Post-Marketing Setting. A Prospective Multicenter Observational Study of 1000 Patients
07:30 AM - 12:00 PM	Abstract	073 - Circulating Perforin+CD8+ and T-Bet+CD8+ Lymphocytes in Relapsing Remitting, Secondary Progressive and Primary Progressive Multiple Sclerosis Patients
07:30 AM - 12:00 PM	Abstract	074 - Response of Human Oligodendrocyte Progenitors to Growth Factors and Axon Signals
07:30 AM - 12:00 PM	Abstract	075 - Mesenchymal Stem Cell Therapy as a Control of Pro-Inflammatory Th1 and Th17 Responses in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	076 - Intrathecal Anti-MOG Antibody Production Is Elevated in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	077 - Bio-Assays for the Investigation of Sub-Lethal Neurobiological Injury in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	078 - IL-11 Producing Cells Are a New T-Cell Subset That Promotes Th17-Differentiation in Patients with Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	079 - Immune-Mediate Changes to the Astrocyte Cytoskeleton as Seen in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	080 - Cerebral Atrophy Is Correlated with White Matter Hyperintensity, but Not with Brain Microbleeds
07:30 AM - 12:00 PM	Abstract	081 - Cerebrovascular Risk Factors Influence Age-Related Memory Decline in APOE E4 Carriers
07:30 AM - 12:00 PM	Abstract	082 - Hemodynamic Correlates of Vascular Risk Factors in Patients with Alzheimer's Disease
07:30 AM - 12:00 PM	Abstract	084 - Association of Vascular Risk Factors and White Matter Hyperintensities with Regional Cerebral Atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort
07:30 AM - 12:00 PM	Abstract	085 - Clinical Correlating Factors and Cognitive Function in Community-Dwelling Healthy Subjects with Cerebral Microbleeds (MBs)
07:30 AM - 12:00 PM	Abstract	086 - Language and Behavior Domains Enhance the Value of the Clinical Dementia Rating Scale
07:30 AM - 12:00 PM	Abstract	087 - NCAT: A Visual Based Cognitive Assessment Tool for Use in a Multiracial Multilingual Population
07:30 AM - 12:00 PM	Abstract	088 - Utility of an Abbreviated Version of the Executive and Social Cognition Battery in the Detection of Executive Deficits in Early Behavioral Variant Frontotemporal Dementia Patients
07:30 AM - 12:00 PM	Abstract	089 - Cardiorespiratory Fitness Is Associated with Brain Atrophy in Early Alzheimer Disease
07:30 AM - 12:00 PM	Abstract	090 - Does REM Sleep Behavior Disorder Improve the Diagnostic Accuracy of Dementia with Lewy Bodies? Validation with an Autopsy Sample
07:30 AM - 12:00 PM	Abstract	091 - Probable REM Sleep Behavior Disorder Is Associated with Decreased Olfaction in Cognitively Normal Subjects: The Mayo Clinic Study of Aging
07:30 AM - 12:00 PM	Abstract	092 - Validation of the Mayo Fluctuations Scale in an Autopsy Confirmed Sample of DLB, AD and Normal Controls
07:30 AM - 12:00 PM	Abstract	093 - Risk of 1-Year Decline in Functional Activities in Dementia with Lewy Bodies and Alzheimer Disease
07:30 AM - 12:00 PM	Abstract	094 - The Evaluation of Alzheimer's Disease (AD) and Lewy Body Disease (LBD) Using Clinical and Semiquantitative MRI Measures
07:30 AM - 12:00 PM	Abstract	095 - Visual Hallucinations, Visuospatial Dysfunction and Brain SPECT Perfusion in Dementia with Lewy Bodies
07:30 AM - 12:00 PM	Abstract	096 - Screening for REM Sleep Behavior Disorder in the Community-Dwelling Elderly: Validation of the Mayo Sleep Questionnaire in the Mayo Clinic Study of Aging
07:30 AM - 12:00 PM	Abstract	097 - Sensitivity of the Clock Drawing Test in Parkinson's Disease Patients with Mild Cognitive Impairment
07:30 AM - 12:00 PM	Abstract	098 - Excessive Daytime Somnolence Is Objectively Demonstrated in Early Dementia with Lewy Bodies but Is Not a Feature of Early Alzheimer's Disease
07:30 AM - 12:00 PM	Abstract	099 - Probable REM Sleep Behavior Disorder in Cognitively Normal Elderly Subjects and Risk of Cognitive Impairment and/or Parkinsonism: The Mayo Clinic Study of Aging
07:30 AM - 12:00 PM	Abstract	100 - Phytic Acid as a Potential Therapy for Alzheimer's Disease
07:30 AM - 12:00 PM	Abstract	101 - Alzheimer's Impairs Responses to Speed Changes in Simulated Self-Movement: A Visual Motion Evoked Potentials Study
07:30 AM - 12:00 PM	Abstract	102 - Differential Activation of Tumor Necrosis Factor Receptors Distinguishes between Brains from Alzheimer's Disease and Non-Demented Patients
07:30 AM - 12:00 PM	Abstract	103 - Aging-Related Down-Regulation of Dynein Causes Accumulation of [alpha]-Synuclein
07:30 AM - 12:00 PM	Abstract	104 - Production and Characterization of High Affinity Rabbit Monoclonal Antibodies to Amyloid [beta] 40 (A[beta]40) and Amyloid [beta] 42 (A[beta]42) Peptides
07:30 AM - 12:00 PM	Abstract	105 - Prolonged Disease Duration Is Associated with Lower Neuritic Amyloid Plaque Burden in Alzheimer's Disease
07:30 AM - 12:00 PM	Abstract	106 - Intracerebroventricular Injection of Tumor Necrosis Factor-[alpha] Monoclonal Antibody (Infliximab) Reduces Cerebral Amyloid Plaques and Neurofibrillary Tangles Rapidly in Aged APP/PS1 Double Transgenic Mice
07:30 AM - 12:00 PM	Abstract	107 - Dimensions of AD Neuropathology: Differential Relationships with Age and ApoE
07:30 AM - 12:00 PM	Abstract	108 - Splicing Isoforms of SORCS1 and APP Processing
07:30 AM - 12:00 PM	Abstract	109 - Deficits in Covert Orienting of Visual Attention in Alzheimer's Disease: Relationship to HMPAO SPECT Measures of Cortical Hypoperfusion
07:30 AM - 12:00 PM	Abstract	110 - Alteration of snRNAs in Amyotrophic Lateral Sclerosis
07:30 AM - 12:00 PM	Abstract	111 - CD4+CD25+ Regulatory T-Cells Suppress Microglial Activation in a Mouse Model of ALS
07:30 AM - 12:00 PM	Abstract	112 - Growth Inhibitory Factor Inhibits the Progression of Amyotrophic Lateral Sclerosis Model Mice
07:30 AM - 12:00 PM	Abstract	113 - Familial ALS-Linked Mutant SOD1 Impairs a Network of RNA-Binding Proteins That Regulate VEGF and Other Cell Survival Factors
07:30 AM - 12:00 PM	Abstract	114 - Oxidative Stress as Target for Neuroprotection in Experimental Models of Amyotrophic Lateral Sclerosis (ALS)
07:30 AM - 12:00 PM	Abstract	115 - Effects of Cholesterol [beta]-D-Glucoside (C[beta]G) on Respiration and Reactive Oxigen Species (ROS) Generation in Rat Brain Mitochondria
07:30 AM - 12:00 PM	Abstract	116 - Peripheral Nerve Inflammation and Muscle Denervation in mSOD1 Transgenic Mice: Which Comes First?
07:30 AM - 12:00 PM	Abstract	117 - Purification of Motor Neurons Derived from Embryonic Stem Cells Cultures
07:30 AM - 12:00 PM	Abstract	118 - Treatment with a Soluble Activin Receptor Type IlB Attenuates Loss of Lean Tissue and Grip Strength in SODG93A Mice
07:30 AM - 12:00 PM	Abstract	119 - Killing Two Birds with One Botox Dose: The Anti-Inflammatory Effects of C. botulinum Toxin Type A
07:30 AM - 12:00 PM	Abstract	120 - Expression of Heat Shock Proteins in Skeletal Muscle from Idiopathic Inflammatory Myopathy and Duchenne Muscular Dystrophy Patients
07:30 AM - 12:00 PM	Abstract	121 - The Dysferlin Interactome
07:30 AM - 12:00 PM	Abstract	122 - Increased Transcript of the Non-Coding [beta]-Site of Amyloid-[beta] Precursor Protein Cleaving Enzyme (BACE1-Antisense) and BACE1-mRNA in Sporadic Inclusion-Body Myositis (s-IBM) Muscle Fibers and in an IBM Model
07:30 AM - 12:00 PM	Abstract	123 - Experimentally-Induced Endoplasmic Reticulum Stress (ERS) Decreases VMA21 and Impairs the Autophagosomal-Lysosomal-System (A-L-S) in Cultured Human Muscle Fibers (CHMFs): Relevance to Sporadic Inclusion-Body Myositis (s-IBM)
07:30 AM - 12:00 PM	Abstract	124 - Altered Pre-mRNA Processing Is a Common Feature of Muscle Cells in Senescence and Myotonic Dystrophy Type 2 (DM2)
07:30 AM - 12:00 PM	Abstract	125 - Treatment of CoQ10 Deficiency Fibroblasts with Ubiquinone Analogs and Vitamin C: Time Dependent Effect on Bioenergetic and Oxidative Stress Status
07:30 AM - 12:00 PM	Abstract	126 - ROS Production, Oxidative Stress, and Cell Death Correlate with the Level of CoQ10 in Fibroblast Models of CoQ10 Deficiency
07:30 AM - 12:00 PM	Abstract	127 - Clinical and Laboratory Features in a Family with an ANT1 (SLC25A4) Gene Mutation: Effects on Monomeric OXPHOS Enzyme Assembly and Supercomplex Formation
07:30 AM - 12:00 PM	Abstract	128 - SURF1 Mutation: Effects on Supercomplex Formation and Monomeric Enzyme Assembly
07:30 AM - 12:00 PM	Abstract	129 - Complex V (ATP Synthase) Mutations: Diverse Effects on Supercomplex Formation and Oxidative Phosphorylation Function
07:30 AM - 12:00 PM	Abstract	130 - Effects of a Novel Complex III (Cytochrome b Subunit) Mutation on Supercomplex Formation in a Patient with Mitochondrial Myopathy
07:30 AM - 12:00 PM	Abstract	131 - Quantitative Oxidative Phosphorylation Enzyme Subunit Western Blot: Role of Testing in a Multifaceted Approach for Diagnosis of Mitochondrial Disease
07:30 AM - 12:00 PM	Abstract	132 - Neuronal Voltage-Gated Potassium Channel Autoimmunity in Children
07:30 AM - 12:00 PM	Abstract	133 - Reduced GLE1 Protein Levels Cause Axonal Growth Defects in Zebrafish Motor Neurons
07:30 AM - 12:00 PM	Abstract	134 - Autoimmune Limbic Encephalitis in a Paediatric Patient
07:30 AM - 12:00 PM	Abstract	135 - Transient Mutism in Para-Infectious Encephalopathy
07:30 AM - 12:00 PM	Abstract	136 - Severe Central and Peripheral Neuro-Lupus: Role of CSF B Cells and Chemokines
07:30 AM - 12:00 PM	Abstract	137 - Increased Susceptibility of the Glut-1 Knockout Mouse to Postnatal Hypoxia
07:30 AM - 12:00 PM	Abstract	138 - Menstrual Migraine in Adolescents
07:30 AM - 12:00 PM	Abstract	139 - Do Children Learn New Motor Skills Differently from Adults?
07:30 AM - 12:00 PM	Abstract	140 - Lithium Promotes Survival and Proliferation of Transplanted Nestin-Expressing Cells Isolated from Neonatal Blood In Vitro and Vivo
07:30 AM - 12:00 PM	Abstract	141 - Effect of Mesenchymal Stem Cell-Derived Neural Progenitors on Demyelination and Immune Cell Infiltration in Mice with Experimental Autoimmune Encephalomyelitis
07:30 AM - 12:00 PM	Abstract	142 - Postconcussion Syndrome after Blast Injuries in OEF [amp] OIF Veterans
07:30 AM - 12:00 PM	Abstract	143 - HIF-1[alpha]-Mediated Neuroprotection on MPP+-Induced Apoptosis in SH-SY5Y Cells
07:30 AM - 12:00 PM	Abstract	144 - Efficacy of Dietary Agmatine Sulfate in Herniated Lumbar Disc-Associated Radiculopathy. A Randomized, Double-Blind, Placebo-Controlled Study
07:30 AM - 12:00 PM	Abstract	145 - Is Confrontation Testing Adequate To Detect Visual Field Defects?
07:30 AM - 12:00 PM	Abstract	146 - Arbaclofen Placarbil Is Efficacious and Safe in a Study of the Treatment of Spasticity Due to Spinal Cord Injury
07:30 AM - 12:00 PM	Abstract	147 - High Triglyceride in Leukoaraiosis-Free Small Vessel Occlusive Stroke
07:30 AM - 12:00 PM	Abstract	149 - Are Levels of the Neuromodulator Adenosine Depressed during Hyperoxia?
07:30 AM - 12:00 PM	Abstract	150 - Increased TGF-[beta] Signaling Underlies the Pathogenesis of Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)
07:30 AM - 12:00 PM	Abstract	151 - Serum Levels of Chemokine CCL2 in Patients with Intracerebral Hemorrhage
07:30 AM - 12:00 PM	Abstract	152 - Tissue Plasminogen Activator Gene Expression in Ischemic Stroke
07:30 AM - 12:00 PM	Abstract	153 - Circulating Levels of Pro-Inflammatory Cytokines after Acute Ischemic Stroke as Markers of Stroke Severity
07:30 AM - 12:00 PM	Abstract	154 - Serum Il-6 as a Marker of Functional Outcome after Acute Ischemic Stroke
07:30 AM - 12:00 PM	Abstract	155 - Intravenous Fibrinolysis 3 to 4.5 Hours after Acute Ischemic Stroke Onset: A Single Institution Experience
07:30 AM - 12:00 PM	Abstract	156 - Successful Intra-Arterial Altepase (IA t-PA) Intervention in Two Pediatric Patients
07:30 AM - 12:00 PM	Abstract	157 - Using IV TPA To Treat 106 Patients with or without IA Interventions in 104 Weeks, the Outcome and Mortality Analysis at Discharge
07:30 AM - 12:00 PM	Abstract	158 - Selection of Antiplatelet at Discharge after Aspirin and Clopidogrel Loading for Acute Ischemic Stroke
07:30 AM - 12:00 PM	Abstract	159 - Outcomes Differences by Mechanism in Stroke Treated with IV tPA: An Unrecognized Pattern?
07:30 AM - 12:00 PM	Abstract	161 - Acute Ischemic Stroke Caused by an Acute Internal Carotid Artery Occlusion: Factors Predicting Better Clinical Outcome in Patients Undergoing Emergent Carotid Endarterectomy
07:30 AM - 12:00 PM	Abstract	162 - A Pivotal Study Evaluating the Ischemic Stroke System (ISS*) for Treatment of Acute Ischemic Stroke up to 24 Hours from Stroke Onset
07:30 AM - 12:00 PM	Abstract	163 - Oxygen Use for Suspected Acute Ischemic Stroke in Pre-Hospital and Emergency Department Settings
07:30 AM - 12:00 PM	Abstract	164 - Erythropoietin May Have Neuroprotective Role in Ischemic Stroke Patients with Advanced Renal Disease
07:30 AM - 12:00 PM	Abstract	165 - Outcome of Surgery for Temporal Lobe Epilepsy Evaluated with Non-Invasive Protocol
07:30 AM - 12:00 PM	Abstract	166 - Survival Analyses between Surgical and Clinical Treatments for Refractory MTLE: A Prospective Study with 5 Years of Follow-Up
07:30 AM - 12:00 PM	Abstract	167 - Preference-Based Quality of Life Measures for Neocortical Epilepsy Surgery Health Outcomes
07:30 AM - 12:00 PM	Abstract	168 - Timing of Surgical Resection of Cavernous Malformation and Seizure Outcome
07:30 AM - 12:00 PM	Abstract	169 - Seizure Response to Vagus Nerve Stimulation: Three Year Follow-Up and Effects of Syndromic Classification
07:30 AM - 12:00 PM	Abstract	170 - Dravet Syndrome and Deep Brain Stimulation: Seizure Control after 10 Years of Treatment
07:30 AM - 12:00 PM	Abstract	171 - A Clinical Trial of Adjunct Carvedilol-CR as a P-Glycoprotein (P-Gp) Inhibitor for Medically-Intractible Epilepsy
07:30 AM - 12:00 PM	Abstract	172 - Lacosamide in Refractory Status Epilepticus: A Report of Four Patients
07:30 AM - 12:00 PM	Abstract	173 - Biopsy-Proven Rasmussen's Encephalitis: Seizure Suppression and Partial Reversal of Deficits with Antiepileptic Medications and Tacrolimus
07:30 AM - 12:00 PM	Abstract	174 - The Approach of the Harvard Epilepsy Botanical Program to the Study of Herbal Therapies for Epilepsy
07:30 AM - 12:00 PM	Abstract	175 - Retention Rate Meta-Analysis and Computational Modeling Results of Second Generation Antiepileptic Drugs in Epilepsy Patients with Partial Onset Seizures
07:30 AM - 12:00 PM	Abstract	176 - Clinical Experience with Generic Levetiracetam in a Tertiary Care Epilepsy Clinic
07:30 AM - 12:00 PM	Abstract	177 - Rapid Titration of Lacosamide with Simultaneous Reduction in Concomitant AEDs Is Well-Tolerated and Effective in Reducing Seizures in Patients with Drug-Resistant Partial-Onset Epilepsy
07:30 AM - 12:00 PM	Abstract	178 - A Multicenter, Open-Label Trial To Assess the Safety and Tolerability of a Single Intravenous Loading Dose of Lacosamide Followed by Oral Maintenance as Adjunctive Therapy in Subjects with Partial-Onset Seizures: An Interim Report
07:30 AM - 12:00 PM	Abstract	179 - Long-Term Efficacy of Lacosamide for Partial-Onset Seizures: An Interim Evaluation of Completer Cohorts Exposed to Lacosamide for up to 36 Months
07:30 AM - 12:00 PM	Abstract	180 - Outcome of Infants with Prenatal Exposure to Lacosamide during the Clinical Development Program
07:30 AM - 12:00 PM	Abstract	181 - Long-Term Safety and Tolerability of Lacosamide for Partial-Onset Seizures: An Interim Evaluation of Patients Exposed to Lacosamide in Double-Blind and Open-Label Trials
07:30 AM - 12:00 PM	Abstract	182 - Pharmacokinetic Evaluation of Intravenous Lacosamide as Short-Term Replacement for Oral Lacosamide in Partial-Onset Seizures
07:30 AM - 12:00 PM	Abstract	183 - Effect of Carisbamate, a Novel Antiepileptic Drug, on Cognition in Three Placebo-Controlled, Healthy Volunteer, Multiple-Dose Studies
07:30 AM - 12:00 PM	Abstract	184 - A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures
07:30 AM - 12:00 PM	Abstract	185 - An Investigation of the Effects of Eslicarbazepine Acetate on Hyponatremia: A Pooled Analysis of Three Double-Blind Phase III Clinical Studies
07:30 AM - 12:00 PM	Abstract	186 - Lacosamide Efficacy in Partial-Onset Seizures with and without Secondary Generalization: A Pooled Analysis of Three Phase II/III Trials
07:30 AM - 12:00 PM	Abstract	187 - Improvement in Patient-Reported Outcomes Seen in Patients Responding to Lacosamide: Pooled QOLIE-31, SSQ and PGIC Data from 3 Phase II/III Clinical Trials
07:30 AM - 12:00 PM	Abstract	188 - Lacosamide Add-On Treatment: Results of Open Label 6 Months Follow-Up
07:30 AM - 12:00 PM	Abstract	189 - Efficacy of Retigabine 600-1200mg/day in Patients with Refractory Epilepsy with Partial-Onset Seizure: Integrated Analysis of Three Randomized Studies
07:30 AM - 12:00 PM	Abstract	190 - Retigabine Provides Effective Adjunctive Therapy in Adults with Refractory Epilepsy with Partial-Onset Seizures, Irrespective of Gender, Race, and Age
07:30 AM - 12:00 PM	Abstract	191 - The Effects of Retigabine on the Pharmacokinetics of Concomitantly Administered Antiepileptic Drugs
07:30 AM - 12:00 PM	Abstract	192 - Retigabine 600, 900, or 1200 mg/Day as Adjunctive Therapy in Adult Patients with Refractory Epilepsy with Partial-Onset Seizures
07:30 AM - 12:00 PM	Abstract	193 - Long-Term Maintenance of Efficacy with Retigabine 600-1200 mg/Day in Adult Patients with Refractory Epilepsy: Extension Study of RESTORE 1
07:30 AM - 12:00 PM	Abstract	194 - Long-Term Maintenance of Efficacy with Retigabine 600-1200 mg/day in Adult Patients with Refractory Epilepsy: Extension Study of RESTORE 2
07:30 AM - 12:00 PM	Abstract	195 - Work Loss and Associated Costs in U.S. Employees with Epilepsy Receiving Multiple Antiepileptic Drugs
07:30 AM - 12:00 PM	Abstract	196 - The Effects of Antiepileptic Drugs in Oral Health
07:30 AM - 12:00 PM	Abstract	197 - Epilepsy in Pregnancy in a Minority Population
07:30 AM - 12:00 PM	Abstract	198 - Carbamazepine Co-Administration with an Oral Contraceptive: Effects on Steroid Pharmacokinetics, Bleeding, and Ovulation
07:30 AM - 12:00 PM	Abstract	199 - Levetiracetam in the Treatment of Idiopathic Generalized Epilepsies: A Long-Term Observational Study
07:30 AM - 12:00 PM	Abstract	200 - Levetiracetam Induced Thrombocytopenia
07:30 AM - 12:00 PM	Abstract	201 - An Investigation of the Effect of Eslicarbazepine Acetate on Cardiac Repolarization: A Pooled Analysis of Over-Read Electrocardiograms from Three Double-Blind Phase III Clinical Studies
07:30 AM - 12:00 PM	Abstract	202 - Effect of Eslicarbazepine Acetate on the Steady-State Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
07:30 AM - 12:00 PM	Abstract	203 - Pregabalin vs Placebo for the Treatment of Partial Onset Seizures in Patients Taking Concomitant Antiepileptic Drugs: An Analysis of Combined Clinical Trials
07:30 AM - 12:00 PM	Abstract	204 - UCB Antiepileptic Drug Pregnancy Registry
07:30 AM - 12:00 PM	Abstract	205 - Electroclinical Features and Results of Intracranial Recordings in Atypical Cases of Mesial Temporal Lobe Epilepsy (mTLE): "A Pseudo-Extratemporal Epilepsy"?
07:30 AM - 12:00 PM	Abstract	206 - Computer Modeling of the Cause and Treatment of Epilepsy in the Dentate Gyrus
07:30 AM - 12:00 PM	Abstract	207 - A Video-EEG Analysis Study of Dialeptic Seizures: In 100 Patients with Generalized and Focal Epilepsies
07:30 AM - 12:00 PM	Abstract	208 - Unilateral Opercular Lesion and Eating-Induced Epileptic Spasms
07:30 AM - 12:00 PM	Abstract	209 - Ictal Lip-Smacking in Temporal Lobe Epilepsy Has a Stereotyped Electrographic Signature
07:30 AM - 12:00 PM	Abstract	210 - Helpless Romantics: Ictal Kissing (IK) as a Release Phenomenon in Non-Dominant Temporal Lobe Epilepsy
07:30 AM - 12:00 PM	Abstract	211 - Utility of Interictal Heart Rate Variability in Lateralizing Epileptogenic Foci
07:30 AM - 12:00 PM	Abstract	212 - Periictal Heart Rate Changes in Patients with Localization-Related Epilepsy
07:30 AM - 12:00 PM	Abstract	213 - A Descriptive Analysis of Prognostic Indicators in Patients with Non-Convulsive Status Epilepticus in a Tertiary Hospital Population
07:30 AM - 12:00 PM	Abstract	214 - Aphasic Status Epilepticus: Electroclinical Correlation
07:30 AM - 12:00 PM	Abstract	215 - Electroclinical Correlates of Postictal Psychosis in a Child
07:30 AM - 12:00 PM	Abstract	216 - Status Epilepticus, Both Convulsive and Non-Convulsive, in the Elderly: A Tertiary-Care Hospital-Based Study in South India
07:30 AM - 12:00 PM	Abstract	217 - Maturational Changes of SSVEPs Elicited by Intermittent Photic Stimulation
07:30 AM - 12:00 PM	Abstract	218 - Infantile Spasms: Retrospective Review of Epilepsy Outcome
07:30 AM - 12:00 PM	Abstract	219 - Association between Clinical, Morphological and Biochemical Findings and Central and Peripheral Nerve Conduction in Late Infantile Metachromatic Leukodystrophy
07:30 AM - 12:00 PM	Abstract	220 - Intraoperative MEP and SEP Monitoring in Spinal Surgery for Predicting Postoperative Minor Motor Deficits
07:30 AM - 12:00 PM	Abstract	221 - Simple Febrile Seizures Plus (SFS+): It Is Okay To Have More Than One Seizure within a 24 Hr Period
07:30 AM - 12:00 PM	Abstract	222 - Clinical Features of Children with Refractory Epilepsy and MRI Evident Versus MRI Occult Malformations of Cortical Development
07:30 AM - 12:00 PM	Abstract	223 - In-Vivo Confocal Microscopy of Meissner Corpuscles as a Measure of Early HIV Neuropathy
07:30 AM - 12:00 PM	Abstract	224 - Sweat Gland Duct Density with Optical Coherence Tomography in Peripheral Neuropathy
07:30 AM - 12:00 PM	Abstract	225 - A Quantitative Device To Test Touch Sensitivity on the Finger Pad
07:30 AM - 12:00 PM	Abstract	226 - Peripheral Nerve Function in HIV-Infection: Electrophysiological and Quantitative Sensory Test Results in the CHARTER Study
07:30 AM - 12:00 PM	Abstract	227 - Pathophysiology of Painful Neuropathy: Correlations of Contact Heat Evoked Potential with Skin Innervation and Features of Neuropathic Pain
07:30 AM - 12:00 PM	Abstract	228 - A Randomized, Placebo-Controlled Trial of Gabapentin Enacarbil in Subjects with Neuropathic Pain Associated with Post-Herpetic Neuralgia
07:30 AM - 12:00 PM	Abstract	229 - Onset of Treatment Response to NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Postherpetic Neuralgia
07:30 AM - 12:00 PM	Abstract	230 - The Neuromuscular Spectrum of Herpes Zoster Infection in the Upper Limb
07:30 AM - 12:00 PM	Abstract	231 - Epidermal Nerve Fiber Density as a Potential Marker for Central Pain Syndromes
07:30 AM - 12:00 PM	Abstract	232 - Multi-Microcramps (MMC) Syndrome: A New Pathogenic Concept of Subtle Lower Motor-Neuron (LMN) Lability Causing Very Disturbing, Continuing Muscle Pains, Sometimes Gratifyingly Treatable [mdash] But Often Misinterpreted as Mysterious "Fibromyalgia" or "Psychogenic"
07:30 AM - 12:00 PM	Abstract	233 - Renal Cell Carcinoma Presenting with Sensory Ataxia Due to Acute Inflammatory Demyelinating Polyneuropathy
07:30 AM - 12:00 PM	Abstract	234 - Sacral Polyradiculitis Due to HSV2 (Elsberg Syndrome): A Report of Two Cases
07:30 AM - 12:00 PM	Abstract	235 - The Occurrence of Central Nervous System Demyelination in Diabetes
07:30 AM - 12:00 PM	Abstract	236 - A Case of Mistaken Identity: Anti-NMDA Receptor Encephalitis in a Young Woman
07:30 AM - 12:00 PM	Abstract	237 - Thiamine Deficiency Presenting with Encephalopathy and Optic Neuropathy after Chemoradiation for Tongue Cancer
07:30 AM - 12:00 PM	Abstract	238 - Evaluation of Central Effects of Diabetes Mellitus by Multimodal Evoked Potentials and Brain Magnetic Imaging Tests
07:30 AM - 12:00 PM	Abstract	239 - Silent Brain Infarctions in Diabetes Mellitus Patients: The Multimodal Evoked Potential Tests Sensitivity and Specificity
07:30 AM - 12:00 PM	Abstract	240 - Neuro-Psychiatric Manifestations of Systemic Lupus Erythematosus: A Monocentric Retrospective Study of 96 Patients
07:30 AM - 12:00 PM	Abstract	241 - Lower Extemity Amyotrophic Diplegia (LAD): Prevalence and Pattern of Weakness
07:30 AM - 12:00 PM	Abstract	242 - Light Sensitivity Due to Erythropoietic Protoporphyria Responds to Oral Prednisone
07:30 AM - 12:00 PM	Abstract	243 - ANCA-Negative Wegener's Granulomatosis Presenting as a Cavernous Sinus Syndrome
07:30 AM - 12:00 PM	Abstract	244 - Treatment of Adult Spasticity with Myobloc[reg] (RimabotulinumtoxinB; BoNT-B) in Clinical Practice: A Multicenter Retrospective Chart Review
07:30 AM - 12:00 PM	Abstract	245 - Serotonin Syndrome after Administration of Milnacipran for Fibromyalgia
07:30 AM - 12:00 PM	Abstract	246 - Effect of Apocynin, a NADPH Oxidase Inhibitor, on Cerebral Miocroglia in Sabra Rat Model of Hypertension
07:30 AM - 12:00 PM	Abstract	247 - Neurological Manifestations of Beh[ccedil]et Disease: Epidemiology, Clinical Characteristics and Management in a Series of Hospitalized Patients
07:30 AM - 12:00 PM	Abstract	248 - MELAS Syndrome Presenting as Pure Word Deafness and Wernicke's Aphasia
07:30 AM - 12:00 PM	Abstract	249 - Selective Cerebellar Degeneration Following Carbon Monoxide Poisoning: A Case Report
07:30 AM - 12:00 PM	Abstract	250 - A Case of Low Dose Oral Methotrexate-Induced Reversible Neurotoxicity
07:30 AM - 12:00 PM	Abstract	251 - Association between Stroke Severity and the Intensity of Periodontitis
07:30 AM - 12:00 PM	Abstract	252 - Autoimmune MuSK-Positive Myasthenia Gravis in Two Sisters
07:30 AM - 12:00 PM	Abstract	253 - P-ANCA-Related Neurological Syndromes; Two Cases with Atypical Presentation
07:30 AM - 12:00 PM	Abstract	254 - Atypical Case of Posterior Reversible Encephalopathy Syndrome in an HIV-Seropositive Patient
07:30 AM - 12:00 PM	Abstract	255 - Facial Onset Sensorimotor Neuronopathy: A Case Series
07:30 AM - 12:00 PM	Abstract	256 - Intracerebral Hemorrhage, CNS Vasculitis, and Sjogren's Syndrome in a 57 Year Old Female: A Case Report
07:30 AM - 12:00 PM	Abstract	257 - Supplement-Associated Hyperammonia after c(K)achetic Episode (SHAKE) Syndrome
07:30 AM - 12:00 PM	Abstract	258 - A Case of Reversible Brainstem Hypertensive Encephalopathy
07:30 AM - 12:00 PM	Abstract	259 - Atypical Presentation of Posterior Reversible Leukoencephalopathy in a Sickle Cell Patient
07:30 AM - 12:00 PM	Abstract	260 - Acute Combined Degeneration Associated with B12 Deficiency and Nitrous Oxide Anesthesia
07:30 AM - 12:00 PM	Abstract	261 - Churg Strauss Syndrome Associated with Asymmetric Neuropathy and Multiple Effusions
07:30 AM - 12:00 PM	Abstract	262 - Intrasinus Thrombolysis of Deep Cerebral Sinus Thrombosis Resulting in Reversible Thalamic Infarcts
07:30 AM - 12:00 PM	Abstract	263 - Is Thrombolysis a Safe Option in Patients with an Unruptured Aneurysms?
07:30 AM - 12:00 PM	Abstract	264 - Prominent Loss of Clinical Benefit among Patients with Acute Ischemic Stroke Treated with Endovascular Treatment after 6 Hours of Symptom Onset
07:30 AM - 12:00 PM	Abstract	265 - Acute Stroke Interventions Based on the Radiographic Time Window for Those Who Present beyond the Current Therapeutic Time Window
07:30 AM - 12:00 PM	Abstract	266 - Use of Intravenous Heparin Prior to CEA in Acute Internal Carotid Ischemic Syndrome: A Preliminary Demonstration of Safety and Possible Efficacy
07:30 AM - 12:00 PM	Abstract	267 - Anesthesia Patterns for Endovascular Therapy in Acute Ischemic Stroke
07:30 AM - 12:00 PM	Abstract	268 - Intravenous Thrombolysis with rt-PA Even within the First-3 Hours Is Not Effective for Large Artery Stroke
07:30 AM - 12:00 PM	Abstract	269 - Role of Vertebral Dominance Pattern in Ischemic Stroke Subtype
07:30 AM - 12:00 PM	Abstract	270 - Reversible Arterial Vasoconstriction in Sturge Weber Syndrome Presenting with Postcoital Headache and Transient Hemiplegia
07:30 AM - 12:00 PM	Abstract	271 - Evaluating Rates of Recanalization and Outcomes in Patients Receiving Full Dose of IV tPA Followed by IA Thrombolytics Versus Followed by Mechanical Intervention
07:30 AM - 12:00 PM	Abstract	272 - Risk of Contrast Induced Nephropathy in Patients Undergoing Endovascular Treatment of Acute Ischemic Stroke
07:30 AM - 12:00 PM	Abstract	273 - Long-Term Clinical and Angiographic Outcomes in Patients with Spontaneous Cervico-Cranial Dissections Treated with Stent Placement
07:30 AM - 12:00 PM	Abstract	274 - Low Risk of Intracranial and Systemic Hemorrhages in Patients Treated with Dual Antiplatelets beyond 1-Month after Neurovascular Angioplasty and Stent Placement
07:30 AM - 12:00 PM	Abstract	275 - Long Term Clinical Outcome of Patients Undergoing Intracranial Stent in the Setting of Acute Ischemic Stroke
07:30 AM - 12:00 PM	Abstract	276 - Patients with Arteriovenous Malformations of the Brain Demonstrate Impaired Cognitive Status at the Time of Diagnosis
07:30 AM - 12:00 PM	Abstract	277 - Effect of Hypertension on Hematoma Volume in an Experimental Model of Intracerebral Hemorrhage
07:30 AM - 12:00 PM	Abstract	278 - Diagnosing Ischemic and Hemorrhagic Complication Post Neuro-Intervention Using a Conebeam CT: A Sensitivity and Specificity Analysis
07:30 AM - 12:00 PM	Abstract	279 - Intravascular Ultrasound (IVUS) Guided Angioplasty of a Carotid Dissection in a Patient with Fibromuscular Dysplasia
07:30 AM - 12:00 PM	Abstract	280 - Evaluating Rate of Recanalization and Outcomes in Patients Receiving Full Dose of IV tPA Bridged to IA Therapy Compared to IA Therapy Alone
07:30 AM - 12:00 PM	Abstract	281 - Immediate Technical Outcome of Elective Symptomatic Carotid Stenting with Embolic Protective Devices Performed by Interventional Neurologists
07:30 AM - 12:00 PM	Abstract	282 - Obesity and Intracranial Stent Thrombosis
07:30 AM - 12:00 PM	Abstract	283 - Exploratory Analysis of Time Delays in Administrating Endovascular Therapy for Acute Ischemic Stroke
07:30 AM - 12:00 PM	Abstract	284 - Manometery Guided Endovascular Management of Dural Sinus Stenosis Via Balloon Angioplasty and Stenting
07:30 AM - 12:00 PM	Abstract	285 - Giant Cell Arteritis Diagnosed by a Cerebellar Infarction: A Case Report
07:30 AM - 12:00 PM	Abstract	286 - Acute Stroke Intervention Using Penumbra Device Intervention Versus Multi-Device Intervention: Effect on Clinical Efficacy and Recanalization Time
07:30 AM - 12:00 PM	Abstract	290 - Evidence Of Regional Cortical Atrophy In Patients With Cerebrotendinous Xanthomatosis
07:30 AM - 12:00 PM	Abstract	291 - Effect of Hyperglycemia after the Correction of Glucose Level or Decreased Body Temperature on the Prognosis of Patients with Hypoglycemic Coma

Faculty Disclosures
Carlayne E. Jackson, MD, FAAN	Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for AAN. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital.
Seemant Chaturvedi, MD, FAHA, FAAN	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Christina Marra, MD, FAAN	Dr. Marra has received publishing royalties from a publication relating to health care. Dr. Marra has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Serge Przedborski, MD, PhD	Dr. Przedborski has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for eLife. The institution of Dr. Przedborski has received research support from NIH. The institution of Dr. Przedborski has received research support from DoD. The institution of Dr. Przedborski has received research support from Ludwig Foudantion. The institution of Dr. Przedborski has received research support from CZI.
Michael Silber, MB, ChB, FAAN	Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Steven A. Sparr, MD, FAAN	Dr. Sparr has nothing to disclose.
Elliot M. Frohman, MD, FAAN	Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
David M. Simpson, MD, FAAN	Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Norman Kachuck, MD, FAAN	No disclosure on file
Lisa R. Rogers, DO, FAAN	Dr. Rogers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure .
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Andres M. Kanner, MD, FAAN	Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.
Carmel Armon, MD, FAAN	Dr. Armon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inbal - Israeli Government Insurance Company. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurological Sciences. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Individual attorney offices. Dr. Armon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Israeli Civil Courts as a court-appointed expert. Dr. Armon has received publishing royalties from a publication relating to health care.
Eric R. Eggenberger, DO, FAAN	Dr. Eggenberger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Welch-Allyn. Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illinois Institute of Technology (IITT). Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Misha-Miroslav Backonja, MD	Dr. Backonja has nothing to disclose.
Jeffrey Rosenfeld, MD, PhD, FAAN	Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ML Biosolutions. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexion. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurizon. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serano/EMD. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anelixis. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Strongbridge Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Rosenfeld has received research support from MT Pharma. The institution of Dr. Rosenfeld has received research support from Alexion. The institution of Dr. Rosenfeld has received research support from Healey ALS Trial Center Mass General.
Nathan B. Fountain, MD, FAAN	Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Coda. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Fountain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BrainStorm. Dr. Fountain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shackleford. Dr. Fountain has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Acumen. Dr. Fountain has stock in Hexokine.
Muhammad Al-Lozi, MD	Dr. Al-Lozi has nothing to disclose.
Phillip L. Pearl, MD, FAAN	Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Stanley H. Appel, MD, FAAN	Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Bashar Katirji, MD, FAAN	Dr. Katirji has nothing to disclose.
Kimford J. Meador, MD, FAAN	The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
Frank G. Gilliam, MD, MPH	No disclosure on file
John Shoffner IV, MD	No disclosure on file
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Robert Knowlton, MD	No disclosure on file
Michael R. Pranzatelli, MD	No disclosure on file
Dennis N. Bourdette, MD, FAAN	Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Joseph F. Quinn, MD, FAAN	Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Ilo Leppik, MD	Dr. Leppik has nothing to disclose.
James L. Frey, MD, FAAN	No disclosure on file
Steven L. Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Lewis has received publishing royalties from a publication relating to health care. Dr. Lewis has a non-compensated relationship as a Secretary General with World Federation of Neurology that is relevant to AAN interests or activities.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Allison Brashear, MD, MBA, FAAN	Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
Richard A. Rudick, MD, FAAN	Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Silva Markovic-Plese, MD, FAAN	Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Markovic-Plese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ��ɫ��. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Richard J. Caselli, MD, FAAN	The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
Mark J. Morrow, MD	No disclosure on file
Charles H. Tegeler, MD	Dr. Tegeler has nothing to disclose.
Marc Fisher, MD, FAAN	Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SimcereUSA. Dr. Fisher has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SimcereUSA. Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NoNo. Dr. Fisher has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
R E. Faught, Jr., MD, FAAN	Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Robert D. Brown, Jr., MD, MPH, FAAN	Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Gregory Krauss, MD	Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch.
Douglas S. Goodin, MD	No disclosure on file
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Eduardo A. De Sousa, MD, FAAN	No disclosure on file
Imad M. Najm, MD	Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Ronald J. Ellis, MD, PhD, FAAN	Dr. Ellis has nothing to disclose.
Mario Masellis, MD	Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. The institution of Dr. Masellis has received research support from Canadian Institutes of Health Research. The institution of Dr. Masellis has received research support from Ontario Brain Institute. The institution of Dr. Masellis has received research support from Weston Brain Institute. The institution of Dr. Masellis has received research support from Washington University. The institution of Dr. Masellis has received research support from Alector. Dr. Masellis has received publishing royalties from a publication relating to health care.
Adeline Vanderver, MD, FAAN	An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Catarina Quinzii Hirano, MD	No disclosure on file
David Z. Wang, DO, FAHA, FAAN	Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Mediwelcome.
Alberto A. Martinez-Arizala, MD, FAAN	Dr. Martinez-Arizala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ricci Tyrrell Johnson and Gret. Dr. Martinez-Arizala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Sadaka Associates. Dr. Martinez-Arizala has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for The Brothers Law Firm. Dr. Martinez-Arizala has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rumberger Kirk. Dr. Martinez-Arizala has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lydecker LLC. Dr. Martinez-Arizala has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Huff, Powell & Bailey. Dr. Martinez-Arizala has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sexton and Sanders.
John W. Krakauer, MD	No disclosure on file
Dennis W. Dickson, MD	Dr. Dickson has nothing to disclose.
Gregory L. Holmes, MD	No disclosure on file
David N. Herrmann, MD, FAAN	Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Osama O. Zaidat, MD, FAAN	Dr. Zaidat has nothing to disclose.
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Dimitrios Kapogiannis, MD	The institution of Dr. Kapogiannis has received research support from National Institute on Aging (NIA/NIH).
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Alexandra Durr, MD	The institution of Dr. Durr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Durr has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. The institution of Dr. Durr has received research support from NIH. The institution of Dr. Durr has received research support from BIOGEN. The institution of Dr. Durr has received research support from MINORYX. The institution of Dr. Durr has received research support from TRIPLETS THERAPEUTICS. The institution of Dr. Durr has received research support from Servier. The institution of Dr. Durr has received research support from ANR. The institution of Dr. Durr has received research support from PTC.
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Anna Nogalska, PhD	No disclosure on file
Tanis J. Ferman, PhD	Ms. Ferman has nothing to disclose.
Aneesh B. Singhal, MD, FAAN	An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (��ɫ��) with Biogen.
Jorge G. Burneo, MD, MSPH, FAAN	Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Elaine J. Skalabrin, MD	No disclosure on file
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Jun Xu, MD	No disclosure on file
Frank R. Sharp, MD	No disclosure on file
Yusuke Nanri, MD	No disclosure on file
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Marc Debouverie, MD	Dr. Debouverie has nothing to disclose.
Pierre Clavelou, MD, PhD	Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
	No disclosure on file
Pierre Krystkowiak, MD, PhD	No disclosure on file
Luc Defebvre	No disclosure on file
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Andrew McKeon, MD	The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Wolf-Ruediger Schabitz, MD	No disclosure on file
Christine B. Hunter, RN, BSN	No disclosure on file
Wei-Dong Le, MD, PhD	No disclosure on file
Peachie N. Moore, BA	No disclosure on file
Shin J. Oh, MD, FAAN	No disclosure on file
Esther Cubo Delgado, MD, PhD, FAAN	Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Osamu Onodera, MD	Dr. Onodera has nothing to disclose.
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Robert D. Fealey, MD	No disclosure on file
Meriem Tazir, MD	No disclosure on file
Tamara Vyshkina, PhD	No disclosure on file
Philippe Coubes, PhD	No disclosure on file
Ana Laura Cif, MD	No disclosure on file
Giovanni Meola, MD, FAAN	No disclosure on file
Maurice Giroud	No disclosure on file
Isao Hozumi, MD, PhD	No disclosure on file
Takashi Inuzuka, MD, FAAN	No disclosure on file
Liang Lu, MD, FAAN	Dr. Lu has nothing to disclose.
Dawn Bowers, PhD	No disclosure on file
Pankaj D. Mehta, PhD	No disclosure on file
Arun V. Talkad, MD, BA	Dr. Talkad has nothing to disclose.
Leonardo Salviati, MD	No disclosure on file
Albert C. Ludolph, MD	Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Ludolph has received personal compensation in the range of $0-$499 for serving as a Consultant for FundaMental Pharma . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biologix FZCo.. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon.
William Camu, MD	No disclosure on file
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Niranjan N. Singh, MD, FAAN	Dr. Singh has nothing to disclose.
Yahia M. Lodi, MD, FAAN	Dr. Lodi has nothing to disclose.
Jan Mares, MD	Dr. Mares has nothing to disclose.
Michael A. Farrell, MB	No disclosure on file
Rina Aharoni, PhD	No disclosure on file
Pietro Tonali, MD	No disclosure on file
Weihua Zhao, MD	No disclosure on file
Jenny Henkel, PhD	No disclosure on file
David R. Beers, PhD	No disclosure on file
Howard S. Rossman, DO	No disclosure on file
Anne Lortie, MD	No disclosure on file
Mohamad Koubeissi, MD, FAAN	Dr. Koubeissi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Philippe Cabre, MD	No disclosure on file
Jean Pelletier, MD, PhD	Dr. Pelletier has nothing to disclose.
Gilles Edan, MD	No disclosure on file
Gregory Couvreur	No disclosure on file
Tianhong Pan, MD, PhD	No disclosure on file
Barry G. Arnason, MD	No disclosure on file
Stuart D. Cook, MD, FAAN	No disclosure on file
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Timon M. Bogumil, MD	No disclosure on file
Filippo Santorelli, MD	No disclosure on file
Douglas R. Jeffery, MD, PhD	No disclosure on file
Paul W. O'Connor, MD	No disclosure on file
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Roy Yaari, MD	Dr. Yaari has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Yaari has stock in Eli Lilly and Company.
Dimitra Papadimitriou, DO	No disclosure on file
Abu Nasar	No disclosure on file
Thomas Koepsell	No disclosure on file
Walter A. Kukull, PhD, FAAN	The institution of Dr. Kukull has received research support from NIH/NIA. Dr. Kukull has a non-compensated relationship as a Associate editor with Alzheimer's and Dementia TRCI (journal) that is relevant to AAN interests or activities. Dr. Kukull has a non-compensated relationship as a Editorial board with Journal of American Geriatrics Soc that is relevant to AAN interests or activities.
Valerie Askanas, MD, PhD, FAAN	No disclosure on file
Eliot A. Licht, MD	No disclosure on file
James R. White, MD	No disclosure on file
Jeanne L. Beattie, MD	No disclosure on file
Thaddeus S. Walczak, MD	No disclosure on file
Jorida Coku	No disclosure on file
Didier Ferriby, MD	No disclosure on file
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
W. K. Engel, MD, FAAN	No disclosure on file
Olivier Godefroy, MD, PhD, FAAN	Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NovoNordisk. Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ELSEVIER.
Ashish Nanda, MD	No disclosure on file
Kourosh Rezania, MD, FAAN	Dr. Rezania has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea. Dr. Rezania has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Paul A. Lapchak, PhD, FAHA	No disclosure on file
Clemence Simonin, MD	No disclosure on file
Rosebud O. Roberts, MD	No disclosure on file
Yonas E. Geda, MD	The institution of Dr. Geda has received research support from NIH.
Toshiaki Takahashi	No disclosure on file
Ariel L. Miller, MD, PhD	Dr. Miller has nothing to disclose.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Ralf Linker	Dr. Linker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Linker has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Linker has received research support from Novartis. The institution of Dr. Linker has received research support from Biogen.
Vanda Lennon, MD, PhD	The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Joseph Hentz	No disclosure on file
Igor Grant, MD	No disclosure on file
Scott L. Letendre, MD	The institution of Dr. Letendre has received research support from National Institutes of Health. The institution of Dr. Letendre has received research support from University at Buffalo. Dr. Letendre has received publishing royalties from a publication relating to health care.
Robert J. Ivnik, PhD	No disclosure on file
Glenn E. Smith, MD, PhD	No disclosure on file
Marjo Van Der Knaap, MD, PhD	The institution of Marjo Van Der Knaap, MD, PhD has received research support from Calico. The institution of Marjo Van Der Knaap, MD, PhD has received research support from Ionis.
Brian-Fred M. Fitzsimmons, MD	No disclosure on file
Daniel Sanak	No disclosure on file
Chris H. Polman, MD	No disclosure on file
Eun Mi Lee, MD	No disclosure on file
Frederick E. Munschauer III, MD, FAAN	Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Ajith Sominanda	No disclosure on file
Jan A. Hillert, MD	Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Rupert Sandbrink, MD, PhD	Dr. Sandbrink has received personal compensation for serving as an employee of Topas Therapeutics. Dr. Sandbrink has received personal compensation for serving as an employee of Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Forward Pharma. Dr. Sandbrink has received stock or an ownership interest from Topas Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Bayer.
Christoph Pohl, MD	No disclosure on file
Christian Confavreux, MD	No disclosure on file
Angelo Quartarone, MD	No disclosure on file
Lisa Elizabeth M. Costelloe, MD	The institution of Dr. Costelloe has received research support from Enterprise Ireland.
De-Hyung Lee, MD	No disclosure on file
Saud I. Khan, MD	Dr. Khan has nothing to disclose.
Laura Herbelin	No disclosure on file
Jagarlapudi M. Murthy, MD, FAAN	Dr. Murthy has nothing to disclose.
Rohit Das, MD, FAAN	Dr. Das has received personal compensation for serving as an employee of Oregon Health Science University. Dr. Das has received personal compensation in the range of $10,000-$49,999 for serving as a Physician Advisor with Concentra .
Murali Ramanathan, PhD	The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Jean-Jacques Martin, MD	No disclosure on file
Ralitza H. Gavrilova, MD	Dr. Gavrilova has nothing to disclose.
Alex Hlubocky, MD	No disclosure on file
Michel G. Clanet, Prof	No disclosure on file
Hyang W. Lee, MD	Dr. Lee has nothing to disclose.
Kyoung-Gyu Choi	No disclosure on file
Richard K. Kim, MD	Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Norbert Schuff	No disclosure on file
Scott Przybelski	Scott Przybelski has nothing to disclose.
Joan T. Moroney, MD, MRCPI	No disclosure on file
Francesca Brett	No disclosure on file
Bassel W. Abou-Khalil, MD, FAAN	The institution of Dr. Abou-Khalil has received research support from Cerevel. The institution of Dr. Abou-Khalil has received research support from Xenon. The institution of Dr. Abou-Khalil has received research support from Otsuka. The institution of Dr. Abou-Khalil has received research support from UCB. The institution of Dr. Abou-Khalil has received research support from SK LIfe Science. The institution of Dr. Abou-Khalil has received research support from Neuroelectrics.
Josemir W. Sander, MD, PhD	No disclosure on file
Robert H. Goertsches, PhD	No disclosure on file
Basil Sharrack, MD, PhD, FAAN	Dr. Sharrack has nothing to disclose.
Michael McDermott	No disclosure on file
Donald S. McCorquodale III, MD, PhD	No disclosure on file
Haitham Hussein, MD, FAAN	Dr. Hussein has nothing to disclose.
Pietro Mazzoni, MD, PhD	No disclosure on file
Barbara E. Tettenborn, MD	No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Cecilia Serrano	No disclosure on file
Violaine K. Harris, PhD	No disclosure on file
Elinor Ben-Menachem, MD, FAAN	Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic.
Kyle B. Womack, MD	The institution of Dr. Womack has received research support from NIH. The institution of Dr. Womack has received research support from Janssen.
Jouko I. Isojarvi, MD, PhD	No disclosure on file
Nancy L. Kuntz, MD, FAAN	Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Paola Pergami, MD, PhD	No disclosure on file
Stephan Schuele, MD, FAAN	Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Schuele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Schuele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thomas Needham. Dr. Schuele has received research support from National Institute of Health.
Warren W. Barker, MA	No disclosure on file
Daniel Reich, MD, PhD	Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Xin Liu	No disclosure on file
Emily Welsh, BA	No disclosure on file
Hermann Stefan, MD, PhD	No disclosure on file
William R. Kennedy, MD, FAAN	No disclosure on file
Mona M. Selim, MD	No disclosure on file
H. R. Brashear, MD, FAAN	No disclosure on file
DaiWai Olson	The institution of DaiWai Olson has received research support from Neuroptics. The institution of DaiWai Olson has received research support from Chiesi.
John P. Seibyl, MD	Dr. Seibyl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Invicro. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Seibyl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Life Molecular Imaging. Dr. Seibyl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Seibyl has received stock or an ownership interest from Invicro.
Joyce A. Cramer	No disclosure on file
Paul Golumbek, MD, PhD	No disclosure on file
Eric M. Reiman, MD	Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Thomas R. Henry, MD, FAAN	Dr. Henry has nothing to disclose.
Derek J. Chong, MD	No disclosure on file
H. R. Jones, Jr., MD	No disclosure on file
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Thomas G. Devlin, MD, PhD	Dr. Devlin has received personal compensation for serving as an employee of Neuroscience Innovation Foundation. Dr. Devlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nova Signal. Dr. Devlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Devlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Devlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Devlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viz,ai. Dr. Devlin has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Neuroscience Innovation Foundation. Dr. Devlin has stock in Nova Signal. Dr. Devlin has stock in Viz.ai. The institution of Dr. Devlin has received research support from Viz.ai. Dr. Devlin has received research support from Nova Signal. Dr. Devlin has received intellectual property interests from a discovery or technology relating to health care.
Jayne Ness, MD	An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
Lucas Restrepo, MD, PhD	Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
John H. Sladky, MD, FAAN	Dr. Sladky has nothing to disclose.
Georgia D. Montouris, MD	No disclosure on file
Steven C. Schachter, MD, FAAN	Dr. Schachter has received personal compensation in the range of $0-$499 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Schachter has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Schachter has received intellectual property interests from a discovery or technology relating to health care. Dr. Schachter has received publishing royalties from a publication relating to health care. Dr. Schachter has received publishing royalties from a publication relating to health care.
Marie-Helene Saint-Hilaire, MD, FRCPC, FAAN	Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec. Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for advarra. Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson study group.
Fernando D. Testai, MD, PhD, FAAN	Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Livingston, Barger, Brandt & Schroeder, L.L.P.. Dr. Testai has received publishing royalties from a publication relating to health care.
Sasha Zivkovic, MD, FAAN	Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical services.
Evelyn Tecoma, MD, PhD	No disclosure on file
Toshio Fukutake, MD, PhD	No disclosure on file
Yves Samson, MD	No disclosure on file
Kevan E. VanLandingham, MD, PhD, FAAN	Dr. VanLandingham has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. VanLandingham has received stock or an ownership interest from Greenwich Biosciences.
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Frank Wiegand, MD, PhD	No disclosure on file
Amy Pace, ScD	No disclosure on file
Ioannis Tsiropoulos, MD	No disclosure on file
Pamela J. Shaw, MD, FRCP, FAAN	No disclosure on file
Amie W. Hsia, MD	The institution of Dr. Hsia has received research support from NIH/NINDS.
Vanja C. Douglas, MD, FAAN	Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Dana Ekstein, MD	No disclosure on file
Paul McMonagle, MD, FRCPI, FRCP	No disclosure on file
Ellen Sidransky, MD	The institution of Dr. Sidransky has received research support from mjff. The institution of Dr. Sidransky has received research support from Roche.
Benito P. Damasceno, MD, PhD	No disclosure on file
John R. Lynch, MD	No disclosure on file
Ricardo Nitrini, MD, FAAN	No disclosure on file
Thomas Leist, MD, PhD, FAAN	Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Muhammad S. Hussain, MD	Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Tiffini S. Voss, MD	No disclosure on file
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Christian Krarup, MD, DMSc, FRcP, FAAN	Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Joseph Maytal, MD	No disclosure on file
Gerald P. Novak, MD	No disclosure on file
Ken Nagata, MD	No disclosure on file
Murray S. Flaster, MD, PhD	No disclosure on file
Felix Rosenow, MD	No disclosure on file
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Pamela Doty, PhD	No disclosure on file
Omotola A. Hope, MD	Dr. Hope has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Kenju Hara, MD	No disclosure on file
Kathleen M. Zackowski, PhD, OTR	Dr. Zackowski has received personal compensation for serving as an employee of National MS Society.
Jonathan H. McKinnon, MD	No disclosure on file
Ivan Rektor	No disclosure on file
Patricia Krief, MD	No disclosure on file
Octavian R. Adam, MD	The institution of Dr. Adam has received research support from Jazz Pharmaceutical. The institution of Dr. Adam has received research support from Sage Therapeutics. The institution of Dr. Adam has received research support from Abbott Laboratories.
Glen Jickling, MD	No disclosure on file
Perinne Charles Ignatiew, MD	No disclosure on file
Kevin O'connor	No disclosure on file
Christophe Verny	No disclosure on file
Wei Liu, MD	Dr. Liu has nothing to disclose.
Joshua Bacon, PhD	No disclosure on file
Talma Brenner, PhD	No disclosure on file
Melissa Brock	Melissa Brock has nothing to disclose.
Anne R. Davis, MD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Exeltis. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for ACLU. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Planned Parenthood Federation of America .
German Echeverry	No disclosure on file
Agnes Fromont	No disclosure on file
Luis Lopez	No disclosure on file
Amrit Saxena	No disclosure on file
Yuko Shimizu, MD, PhD	Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Japan.. Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Shimizu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chigai Pharma CoLtd.
Bernhard Steinhoff	Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $0-$499 for serving as a Consultant for B.Braun Melsungen. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precisis. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Bernhard Steinhoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Bernhard Steinhoff has received research support from UCB. The institution of Bernhard Steinhoff has received research support from Eisai. The institution of Bernhard Steinhoff has received research support from SK LIfe Science.
Mohamed Teleb, MD	Dr. Teleb has nothing to disclose.
Jeffrey Tobias, MD	No disclosure on file
Yasumasa Yamamoto	Yasumasa Yamamoto has nothing to disclose.
Takashi Yamazaki, MD, PhD	No disclosure on file
Hong Yang, MD	No disclosure on file
Xin Zhang	No disclosure on file
Maryna Skliut, MD	Dr. Skliut has nothing to disclose.
David Z. Rose, MD	Dr. Rose has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Chiesi USA. Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL-Behring .
Marcia E. Morita-Sherman, MD	An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Kanjana Unnwongse, MD	No disclosure on file
Jean-Michel Gracies, MD	No disclosure on file
Stuart Yablon, MD	No disclosure on file
Richard L. Barbano, MD, PhD, FAAN	Dr. Barbano has received personal compensation for serving as an employee of State of New York/Office of Mental Health. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Barbano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Barbano has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Visual Dx. Dr. Barbano has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for R L Barbano, MD,PhD, PLLC. The institution of Dr. Barbano has received research support from Fox Foundation. The institution of Dr. Barbano has received research support from Dystonia Study Coalition. The institution of Dr. Barbano has received research support from Revance. Dr. Barbano has received intellectual property interests from a discovery or technology relating to health care.
W. C. LaFrance, Jr., MD, MPH, FAAN	Dr. LaFrance has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medico-legal work.. The institution of Dr. LaFrance has received research support from Department of Defense. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has received publishing royalties from a publication relating to health care. Dr. LaFrance has a non-compensated relationship as a Steering Committee Member with Xenon that is relevant to AAN interests or activities.
Vijayshree Yadav, MD, FAAN	Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Geoffrey Ahern, MD, PhD	Dr. Ahern has nothing to disclose.
Wendy Chao, DO	No disclosure on file
David E. Friedman, MD	No disclosure on file
Rajiv Padmanabhan, MD	Dr. Padmanabhan has nothing to disclose.
Barbara Teter, PhD MPH	No disclosure on file
Jacek Losy, MD	No disclosure on file
Ayman P. Tourbah	No disclosure on file
Joseph M. Ferrara, MD, FAAN	No disclosure on file
Arthur R. Dick, MD	No disclosure on file
Karola Beckmann	No disclosure on file
Carlos A. Guerreiro, MD, FAAN	No disclosure on file
Sophie Crozier	No disclosure on file
Malcolm H. Gottesman, MD, FAAN	No disclosure on file
Mustafa Khan, MD	Dr. Khan has nothing to disclose.
Brent P. Goodman, MD	Dr. Goodman has nothing to disclose.
Jennifer R. Molano, MD, FAAN	Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Maja Tippmann-Peikert, MD	Dr. Tippmann-Peikert has nothing to disclose.
Eli S. Neiman, DO	No disclosure on file
Beatriz Dorado	No disclosure on file
Amer Malik, MD	Dr. Malik has nothing to disclose.
Lily Wong-Kisiel, MD, FAAN	Dr. Wong-Kisiel has nothing to disclose.
Aarti Sarwal, MD, FAAN	Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Radoslav Raychev, MD	Dr. Raychev has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapid Medical . Dr. Raychev has stock in Rapid Medical . Dr. Raychev has stock in Perflow Medical. Dr. Raychev has stock in Neuronics Medical . Dr. Raychev has stock in Time is Brain INC. Dr. Raychev has received intellectual property interests from a discovery or technology relating to health care. Dr. Raychev has received intellectual property interests from a discovery or technology relating to health care.
Sandrine Deltour, MD	No disclosure on file
Randall L. Woltjer	Randall L. Woltjer has nothing to disclose.
Ya-Ping Yang	No disclosure on file
Chunfeng Liu	No disclosure on file
Leslie C. Baxter, PhD	No disclosure on file
Frederique Bouyx Etcharry, MD	No disclosure on file
Susan M. Resnick, PhD	No disclosure on file
Michael L. Rosenberg, MD	Dr. Rosenberg has nothing to disclose.
Christel Renoux	No disclosure on file
Yusuke Yakushiji, MD, PhD	No disclosure on file
Aamir Badruddin, MD	Dr. Badruddin has received intellectual property interests from a discovery or technology relating to health care.
Hebah Hefzy, MD	No disclosure on file
Patrick Hautecoeur	No disclosure on file
Maurizio Leone, MD	Dr. Leone has nothing to disclose.
Veronique Miron	No disclosure on file
Michael P. Macken, MD, MRCPI	Dr. Macken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharma. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Macken has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LifeSciences. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. The institution of Dr. Macken has received research support from LivaNova.
Jamie Forlenza	No disclosure on file
Anthony L. Ritaccio, MD, FAAN	The institution of Dr. Ritaccio has received research support from NIH. Dr. Ritaccio has received intellectual property interests from a discovery or technology relating to health care.
E. Ann Yeh, MD, MA, FRCPC	Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Vladimiro Sinay, MD	No disclosure on file
Teneille Gofton, MD	The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. The institution of Dr. Gofton has received research support from Lawson Health Research Institute. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Galeno Rojas, MD	No disclosure on file
Christine I. Dali, MD	Dr. Dali has received personal compensation for serving as an employee of Orphazyme A/S .
Marilisa M. Guerreiro, MD	No disclosure on file
Devanshi Gupta, MD, FAAN	Dr. Gupta has nothing to disclose.
Giovanni Schifitto, MD	No disclosure on file
Elizabeth Potter, DO, PhD	No disclosure on file
Olivier Casez, MD	Dr. Casez has nothing to disclose.
Lauren C. Hyams, PhD	No disclosure on file
Genevieve Langley	No disclosure on file
Ignacio Casanova	No disclosure on file
Michael Hecker, PhD	No disclosure on file
Jennifer Lachey	No disclosure on file
Raffaella Migliaccio	Raffaella Migliaccio has nothing to disclose.
Ugo Paolucci, MD	No disclosure on file
Munish K. Goyal, MD, FAAN	No disclosure on file
Craig M. Zaidman, MD	Dr. Zaidman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sarepta. The institution of Dr. Zaidman has received research support from Washington University in St Louis. The institution of Dr. Zaidman has received research support from Novartis.
Geertrui F. Vanhove, MD, PhD, MBA	No disclosure on file
Gordon A. Irving, MD	No disclosure on file
Deborah L. Renaud, MD	No disclosure on file
Brajesh K. Agrawal, MD	No disclosure on file
Marie F. Grill, MD	Dr. Grill has nothing to disclose.
Winnie C. Pao, MD	No disclosure on file
Gregory S. Aaen, MD	Dr. Aaen has nothing to disclose.
Pegah Afra, MD, FAAN	The institution of Dr. Afra has received research support from Neuroelectrics. The institution of Dr. Afra has received research support from Xenon Pharmaceuticals. Dr. Afra has a non-compensated relationship as a board member (representing AAN) with CoA-NDT that is relevant to AAN interests or activities.
Yazan Alderazi, MD, MB BCh BAO	No disclosure on file
Amy C. Nielsen, DO	No disclosure on file
Rohan Arora, MD	The institution of Dr. Arora has received research support from Bayer.
Gary Bennett, MD	No disclosure on file
Brigette Biolsi	No disclosure on file
Alzira A. Carvalho, MD	No disclosure on file
Chakorn Chansakul, MD	No disclosure on file
Shan Chen, MD, PhD	Dr. Chen has nothing to disclose.
Xin Cheng	No disclosure on file
Ann Marie Collier, MD, FAAN	Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW BIosciences. Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Collier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Collier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for LivaNova. Dr. Collier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK lifescience.
Thomas Cronin	No disclosure on file
Qiao Ling Cui, MD	No disclosure on file
Peter Darlington, PhD	No disclosure on file
Manuela De Stefano	No disclosure on file
Dawn P. Gill, PhD	No disclosure on file
Antonio Gil-Nagel, MD	Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Victoria Gonzalez Martinez, MD	No disclosure on file
Mark Gorman, MD	The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Alla Borisovna Guekht, PhD	The institution of Prof. Guekht has received research support from Russian Science Foundation .
Daniel M. Harrison, MD, FAAN	Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Physicians. The institution of Dr. Harrison has received research support from Roche-Genentech. Dr. Harrison has received publishing royalties from a publication relating to health care.
Christophe Hotermans, MD, PhD	No disclosure on file
Tomohiko Ishihara	Tomohiko Ishihara has nothing to disclose.
Eun Hye Jeong, MD	No disclosure on file
Junaid Kalia, MD	No disclosure on file
Osamu Kano, MD, PhD	Dr. Kano has nothing to disclose.
Amit Kansara, MD	Dr. Kansara has nothing to disclose.
Eric Klawiter, MD, FAAN	Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Volker A. Knappertz, MD	Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Sutura Pharmaceutical . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care.
Masaki Kobayashi, MD	No disclosure on file
Sachiko Kubo	No disclosure on file
Doris Kung, DO, FAAN	Dr. Kung has received personal compensation for serving as an employee of Aquifer. The institution of Dr. Kung has received research support from RxFunction. Dr. Kung has received publishing royalties from a publication relating to health care. Dr. Kung has received personal compensation in the range of $0-$499 for serving as a Workgroup member with NBME. Dr. Kung has received personal compensation in the range of $500-$4,999 for serving as a Editor with Aquifer.
Alexander Kunz, MD	No disclosure on file
Bing Liao, MD	The institution of Dr. Liao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenex.
Rimas V. Lukas, MD	Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Lukas has received research support from BMS. The institution of Dr. Lukas has received research support from BrainUp. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from Ziopharm.
Michael J. Lyerly, MD, FAAN	Dr. Lyerly has nothing to disclose.
Manoj Malhotra, MD	Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Facundo Manes	No disclosure on file
Larisa Miller, PharmD	Larisa Miller, PharmD has received personal compensation for serving as an employee of Alexion Pharmaceuticals, Inc. Larisa Miller, PharmD has received stock or an ownership interest from Alexion Pharmaceutical, Inc.
Sarah A. Morrow, MD, MSC, FRCPC, FAAN	Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Jean-Luc C. Mougeot, PhD	No disclosure on file
Imaharu Nakano, MD	No disclosure on file
Ugo Nocentini	No disclosure on file
Tatjana Novakovic-Agopian, PhD	No disclosure on file
Yann Pereon, MD, PhD	No disclosure on file
Alexander V. Panov, PhD	No disclosure on file
Gunjan Parikh, MD	The institution of Dr. Parikh has received research support from Department of Defense. The institution of Dr. Parikh has received research support from NINDS. The institution of Dr. Parikh has received research support from NIH.
Alaleh Raji, MD	No disclosure on file
Gregory A. Rippon, MD, FAAN	Dr. Rippon has received personal compensation for serving as an employee of Genentech. Dr. Rippon has stock in Genentech.
G. David Rudd, PharmD, MS	No disclosure on file
Kinshuk Sahaya, MD, FAES, FAAN	Dr. Sahaya has nothing to disclose.
Jasbir Seehra, PhD	Dr. Seehra has received personal compensation for serving as an employee of Keros Therapeutics. Dr. Seehra has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Modal Therapeutics. Dr. Seehra has or had stock in Keros Therapeutics.
Yong Shen	No disclosure on file
Patricio Soares-da-Silva	Patricio Soares-da-Silva has received personal compensation for serving as an employee of Bial - Portela & Cª S.A.. Patricio Soares-da-Silva has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Bial - Portela & Cª S.A..
Stephanie Syc-Mazurek, MD, PhD	Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Nauman Tariq, MD	Dr. Tariq has received personal compensation for serving as an employee of NC neurological society .
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Christine Till, PhD	No disclosure on file
Mark Versavel, MD, PhD	An immediate family member of Dr. Versavel has received personal compensation for serving as an employee of Cerevel. Dr. Versavel has received personal compensation for serving as an employee of Eliem. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bial. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Grunenthal. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Dr. Versavel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Versavel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aptinyx. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alzheon. Dr. Versavel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Finch. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maplight. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxix. Dr. Versavel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Confo.
Jingtian Wang, MD, PhD	No disclosure on file
Christina V. Warner	No disclosure on file
George R. Wilmot, MD, PhD	Dr. Wilmot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar Therapeutics. The institution of Dr. Wilmot has received research support from Friedrich Ataxia Research Alliance. The institution of Dr. Wilmot has received research support from National Ataxia Foundation. The institution of Dr. Wilmot has received research support from NIH. The institution of Dr. Wilmot has received research support from Reata. The institution of Dr. Wilmot has received research support from Biohaven Pharmaceuticals.
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Helen S. Mayberg, MD	Dr. Mayberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott Neuromodulation. Dr. Mayberg has received intellectual property interests from a discovery or technology relating to health care.
Carla D'Agostino, PhD	No disclosure on file
Megan Hyland, MD	The institution of Dr. Hyland has received research support from Biogen. The institution of Dr. Hyland has received research support from PCORI.
Guillermo E. Solorzano, MD	Dr. Solorzano has nothing to disclose.
Jay A. Van Gerpen, MD, FAAN	No disclosure on file
Chantelle T. Hrazdil, MD	No disclosure on file
Jan L. De Bleecker, MD, PhD, FAAN	Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro.
Haythum O. Tayeb, MD	Dr. Tayeb has nothing to disclose.
Georges Naasan, MD	Dr. Naasan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech .
Michael G. Abraham, MD	Dr. Abraham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker Neurovascular.
Nozomi Akanuma, MD	No disclosure on file
Tomoyuki Akiyama, MD	No disclosure on file
Katayoun Alikhani, MD	Dr. Alikhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apotex, Biogen, Bristol Myers Squibb, EMD Serono, Novartis, Roche, Sanofi Genzyme.
Juliann W. Allred, MD	No disclosure on file
Philippe Amouyel, MD, PhD	No disclosure on file
Danielle M. Andrade, MD	The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities.
Thimmappa S. Anekonda	No disclosure on file
Jose Aparicio	No disclosure on file
Olga Azrilin, MD	No disclosure on file
Walter Bartynski	No disclosure on file
Anna P. Batocchi	No disclosure on file
Otto Berger	No disclosure on file
Johan H. Berghuis, MD	No disclosure on file
Regina Berkovich, MD, PhD	The institution of Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Biogen, Genentec, Mallincrodt, Sanofi, Novartis, . Dr. Berkovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentec, Sanofi, Merck . Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion, Biogen, Sanofi, Merck, Mallincrodt . The institution of Dr. Berkovich has received research support from Biogen, Sanofi, Merck.
Lauren A. Beslow, MD	Dr. Beslow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various . The institution of Dr. Beslow has received research support from NIH. Dr. Beslow has received publishing royalties from a publication relating to health care.
Ala P. Birca, MD	No disclosure on file
Karen Blitz-Shabbir, DO	No disclosure on file
Brendon P. Boot, MD, MBBS	Dr. Boot has received personal compensation for serving as an employee of BlueRock Therapeutics. Dr. Boot has stock in Eyepoint Pharmaceuticals.
Simon Borghs	No disclosure on file
Niels Borgstein, MD	No disclosure on file
Alexander U. Brandt, MD	No disclosure on file
Milan Brazdil, MD	No disclosure on file
Catherine Brown, ANP	No disclosure on file
Margaret E. Burnett, MD	Dr. Burnett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prism. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. Dr. Burnett has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Burnett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Burnett has received research support from Genentech.
Bernadette Calabek, MD	No disclosure on file
Tracie Caller, MD, MPH, FAAN	Dr. Caller has nothing to disclose.
Lionel Carmant, MD	No disclosure on file
Maria-Jose Catalan, MD, PhD	No disclosure on file
Albi J. Chalissery, MD	No disclosure on file
Siresha Chaluvadi, MD	No disclosure on file
Peii Chen	No disclosure on file
Yong Chen, MD	No disclosure on file
Robert Chinnapongse, MD	Dr. Chinnapongse has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Chinnapongse has stock in Greenwich Biosciences.
Ezra Cohen, MD, BA	No disclosure on file
Amanda Cole	No disclosure on file
Arnaldo N. Da Silva, MD	No disclosure on file
Alicia C. De Vivo	No disclosure on file
Marie Deluca	No disclosure on file
Lizbeth S. DePadua, MD	No disclosure on file
Jay D. Desai, MD	Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aquestive. The institution of Dr. Desai has received research support from Neurelis, Aquestive, Ovid, Novartis, UCB.
Daniel Desgrandchamps, MD	No disclosure on file
Radhika Dhamija, MD, FAAN	Dr. Dhamija has nothing to disclose.
Adam Doble	No disclosure on file
Dobrin Dobrev, MD	No disclosure on file
Charles J. Duffy, MD, PhD	Dr. Duffy has nothing to disclose.
Cecile Duru, MD	No disclosure on file
Christopher P. Eckstein, MD	The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme.
Katherine McDonell, MD	The institution of Dr. McDonell has received research support from NINDS.
Andrea E. Eggert, PharmD, BCPP	No disclosure on file
Mohammed A. ElSherif, MD, PhD, FAAN	Dr. ElSherif has nothing to disclose.
Eric Ericson, MD	No disclosure on file
Robert Fekete, MD	Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Neuroscience, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Adamas Pharmaceutical, Inc.. Dr. Fekete has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine Biosciences, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals, Inc.. Dr. Fekete has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda Therapeutics, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion, Inc.. Dr. Fekete has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink, Inc.. The institution of Dr. Fekete has received research support from Lundbeck. Dr. Fekete has received publishing royalties from a publication relating to health care. Dr. Fekete has a non-compensated relationship as a Neurological Working Group Member with Alliance for Patient Access that is relevant to AAN interests or activities.
Roberto Fernandez, MD, PhD	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a webinar speaker with Quest Diagnostics .
Olga Fernandez Arconada	No disclosure on file
Ricardo Fernandez-Bolanos, MD	No disclosure on file
Scott Findley	No disclosure on file
Giovanni Frisullo, PhD	Dr. Frisullo has nothing to disclose.
Leo Galvin, MD, MRCPI	No disclosure on file
Ayman A. Gheith, MD	No disclosure on file
Peter Giacobbe	No disclosure on file
Gad M. Gilad, PhD	No disclosure on file
Martin Gizzi, MD, PhD, FAAN	No disclosure on file
Bradley H. Gleason, MD	No disclosure on file
Cristina Y. Go, MD	Dr. Go has nothing to disclose.
Cyril Goizet	No disclosure on file
Andrew Gomez-Vargas, MD	No disclosure on file
Rebecca Gottschalk	No disclosure on file
Ole Graff, MD	Dr. Graff has received personal compensation for serving as an employee of AbbVie. Dr. Graff has stock in AbbVie.
Matthew Grantz, MD	No disclosure on file
Alison S. Griffiths, RN	No disclosure on file
Bella Gross, MD	No disclosure on file
Katrin Gross-Paju, MD, PhD	Dr. Gross-Paju has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Gross-Paju has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gross-Paju has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Silvia Guerrera, PhD	No disclosure on file
Petra Haitova, MD	No disclosure on file
Sulev Haldre, PhD	No disclosure on file
R N. Harden, MD	No disclosure on file
Kazunori Hashimoto	No disclosure on file
Ameer Hassan, DO	Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Diogo C. Haussen, MD	Dr. Haussen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stryker. Dr. Haussen has received stock or an ownership interest from Viz AI.
Peter Hitzenberger	No disclosure on file
Ashley J. Hood	No disclosure on file
Lindsay A. Horton, MD	Dr. Horton has nothing to disclose.
William J. House, MD	No disclosure on file
F. Jacob Huff, MD, FAAN	No disclosure on file
Masahiro Iguchi, MD, PhD	No disclosure on file
Tetsuhiko Ikeda, MD	No disclosure on file
Takeshi Ikeuchi, MD	Dr. Ikeuchi has nothing to disclose.
Tsutomu Iseda, MD	No disclosure on file
Manouchehr Javidan, MD	No disclosure on file
Yu-Ri Jeong	No disclosure on file
Jitesh K. Kar, MD, MBBS	Dr. Kar has nothing to disclose.
Maya Katz, MD	Dr. Katz has received research support from NIH.
Sidney Kennedy, MD	No disclosure on file
Shaan Khurshid	No disclosure on file
Bomi Kim, MD	No disclosure on file
Michail Koutroumanidis	No disclosure on file
Jan Kucera, MD	No disclosure on file
Tobias B. Kulik, MD, FAAN	Dr. Kulik has nothing to disclose.
Constantina Lafoyiannis	No disclosure on file
Clotilde Lagier-Tourenne	No disclosure on file
Eric Lancaster, MD, PhD	Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
Bernhard G. Landwehrmeyer, MD	Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA PHARMACEUTICALS INC, San Diego, CA. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck Valby, Denmark. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AOP Orphan Pharmaceuticals AG, Vienna, Austria. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Remix Therapeutics, Inc., Cambridge, MA. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HSG Clinical Research, Inc. Dr. Landwehrmeyer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann-La Roche Ltd, Basel, Switzerland. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma AG, Grenzach/Whylen, Germany. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharma AG, Basel, Switzerland. The institution of Dr. Landwehrmeyer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharma AG, Basel, Switzerland. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics, Inc., South Plainfield, NJ . Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Triplet Therapeutics, Inc. Cambridge, MA. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharma. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Pharma AG, Grenzach/Whylen, Germany. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche Ltd, Basel, Switzerland. Dr. Landwehrmeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma AG, Basel, Switzerland. The institution of Dr. Landwehrmeyer has received research support from CHDI Foundation. The institution of Dr. Landwehrmeyer has received research support from European Commission. The institution of Dr. Landwehrmeyer has received research support from German Federal Government BMBF. The institution of Dr. Landwehrmeyer has received research support from German Research Council DFG. Dr. Landwehrmeyer has received publishing royalties from a publication relating to health care. Dr. Landwehrmeyer has received publishing royalties from a publication relating to health care.
Melanie Langlois, MD	No disclosure on file
Lan Lee	No disclosure on file
Robert F. Leroy, MD	No disclosure on file
Lester Y. Leung, MD	Dr. Leung has received research support from NIH.
Bingbing Li	Bingbing Li has received personal compensation for serving as an employee of Novartis.
Roland Liblau	Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-genzyme. Roland Liblau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Servier. Roland Liblau has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Immunology. The institution of Roland Liblau has received research support from Roche. The institution of Roland Liblau has received research support from ARSEP. The institution of Roland Liblau has received research support from Fondation pour la Recherche Médicale. The institution of Roland Liblau has received research support from Population Bio UK, Inc. The institution of Roland Liblau has received research support from ANR.
Nita A. Limdi	No disclosure on file
Aaron Lord, MD	Dr. Lord has nothing to disclose.
Malin Ryner	No disclosure on file
Yasuhiro Maeda, MD	No disclosure on file
Soe S. Mar, MD, FAAN	The institution of Dr. Mar has received research support from NIH.
Cecilia Marta, PhD	No disclosure on file
Mayank Mathur, MD	No disclosure on file
Luis C. Mayor-Romero, MD	Dr. Mayor-Romero has nothing to disclose.
Carrie L. McClung	No disclosure on file
David L. McDonagh, MD	No disclosure on file
Sonal Mehta, MD	Dr. Mehta has nothing to disclose.
Françoise Menguy-Vacheron, PhD	No disclosure on file
Christina Meyer	No disclosure on file
Stephanie R. Milazi, PhD	No disclosure on file
Michael R. Misch	No disclosure on file
Nesanet Mitiku, MD	No disclosure on file
Lydiane Mondot	Lydiane Mondot has nothing to disclose.
Gregoire Morisse, MSc	No disclosure on file
Hermann Moser	No disclosure on file
Mohammad Moussavi, MD	Dr. Moussavi has nothing to disclose.
Iryna Muzyka, MD	Dr. Muzyka has nothing to disclose.
Lauren Mylacraine	No disclosure on file
Steffen Naegel, MD	No disclosure on file
Anjana Nair, MD	No disclosure on file
Michael E. Newmark, MD, FAAN	No disclosure on file
Ke Ning, MD, PhD	No disclosure on file
Hiroaki Nozaki, MD, PhD	No disclosure on file
Adel Olshansky, MD	No disclosure on file
Spozhmy Panezai, MD	Dr. Panezai has nothing to disclose.
Josef Parvizi, MD, PhD	Dr. Parvizi has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Parvizi has or had stock in Ceribell.Dr. Parvizi has received intellectual property interests from a discovery or technology relating to health care.
Toni Pearson, MBBS	Dr. Pearson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Pearson has received research support from NIH.
Dominique Peppers, DO	No disclosure on file
Michael D. Perloff, MD, PhD	Dr. Perloff has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for several law firms/Universities.
Margaret A. Petty, PhD	No disclosure on file
Nathalie Philippi	No disclosure on file
Juan Piantino, MD	Dr. Piantino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Cognition.
Jagan Pillai, MD, PhD, FAAN	Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Nature. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. The institution of Dr. Pillai has received research support from Alzheimer's Association. The institution of Dr. Pillai has received research support from Keep Memory Alive Foundation . The institution of Dr. Pillai has received research support from NIA. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with DOD. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with RGC Hong kong.
Domenico Plantone	No disclosure on file
Gayle R. Pletsch, MD	No disclosure on file
Jesus Porta-Etessam	No disclosure on file
Roger J. Porter, MD, FAAN	Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bright MInds Bioscience. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobah. Dr. Porter has received publishing royalties from a publication relating to health care.
Karen M. Powers, MD	No disclosure on file
Sathyanath Rajasekharan, PhD	No disclosure on file
Razi M. Rashid, MD	No disclosure on file
Bernd F. Remler, MD	No disclosure on file
Sakina J. Rizvi	No disclosure on file
David S. Russell, MD, PhD	Dr. Russell has received personal compensation for serving as an employee of Invicro. Dr. Russell has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. The institution of Dr. Russell has received research support from Biogen. The institution of Dr. Russell has received research support from Roche. The institution of Dr. Russell has received research support from Voyager. The institution of Dr. Russell has received research support from Eisai. The institution of Dr. Russell has received research support from Neuraly. The institution of Dr. Russell has received research support from Michael J. Fox Foundation. The institution of Dr. Russell has received research support from National Institutes for Health. The institution of Dr. Russell has received research support from Eli Lilly. The institution of Dr. Russell has received research support from Aprinoia.
Sonemany Salinthone, PhD	Dr. Salinthone has nothing to disclose.
Ajay Sampat, MD	No disclosure on file
Francisco M. Sanchez Caballero, MD	No disclosure on file
Fernando Sanchez Lopez	No disclosure on file
Sita J. Sattaluri	Dr. Sattaluri has nothing to disclose.
Bernadette M. Schoneburg, MD	No disclosure on file
Daniel R. Scoles, PhD, FAAN	The institution of Dr. Scoles has received research support from NIH.
Parastou Shilian, DO	No disclosure on file
Marvin S. Sih, MD	No disclosure on file
Ondrej Skoda, MD	Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Ondrej Skoda, MD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Meditorial.
Matthew Smith, MD	Dr. Smith has received personal compensation for serving as an employee of University Health Associates. An immediate family member of Dr. Smith has received personal compensation for serving as an employee of University Health Associates. Dr. Smith has received personal compensation for serving as an employee of West Virginia University. An immediate family member of Dr. Smith has received personal compensation for serving as an employee of West Virginia University. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pion, Nerone, Girman, Winslow, & Smith PC. Dr. Smith has received stock or an ownership interest from ROM Technologies.
Nidhi Sood	No disclosure on file
David A. Stamler, MD	Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics.
Mariusz Stasiolek, MD	Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Stasiolek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Ariel Stock	No disclosure on file
Tanya-Marie M. Sweeney, MD	No disclosure on file
Yuki Takashima, MD	No disclosure on file
Yazhong Tao	No disclosure on file
Joseph Tarsia, MD	Dr. Tarsia has nothing to disclose.
Inmaculada Tasset, MD	No disclosure on file
Jinny O. Tavee, MD	Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. The institution of Dr. Tavee has received research support from CSL Behring. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
Edward Tay, MD	No disclosure on file
Jan-Mendelt Tillema, MD	Dr. Tillema has nothing to disclose.
Shinya Tokuhiro, PhD	No disclosure on file
Larry Tran, MD	No disclosure on file
Orla Tuohy, MD	No disclosure on file
Paivi M. Ullner, MD	No disclosure on file
Chiara Valori, PhD	No disclosure on file
Brandon P. Vasquez	No disclosure on file
Kavitha Velicheti, MD	No disclosure on file
Aad Verrips, MD, PhD	No disclosure on file
Erik Wallstroem, MD, PhD	Dr. Wallstroem has received personal compensation for serving as an employee of Sanofi. Dr. Wallstroem has stock in Sanofi. Dr. Wallstroem has received intellectual property interests from a discovery or technology relating to health care.
Zeng Y. Wang, MD, PhD, FAAN	Dr. Wang has nothing to disclose.
H. S. White, PhD	No disclosure on file
Michael Wilder, MD	No disclosure on file
Richard Winn, MD	No disclosure on file
Lynn Wiryasaputra	No disclosure on file
Marcin Wnuk, MD	Dr. Wnuk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen, Bayer, Biogen, Merck, Neuraxpharm, Novartis, Roche, Sanofi. Dr. Wnuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Merck, Neuraxpharm. Dr. Wnuk has received research support from Medical Research Agency. Dr. Wnuk has received publishing royalties from a publication relating to health care.
Valerie Wolff	No disclosure on file
Annie Yang, MD	Dr. Yang has nothing to disclose.
Hui-Jun Yang, MD	No disclosure on file
Julian Yang, MD	No disclosure on file
Larisa Yedigarova	Larisa Yedigarova has received personal compensation for serving as an employee of AbbVie. Larisa Yedigarova has received stock or an ownership interest from AbbVie.
Katia Youssov	No disclosure on file
Chiara Zavanone, MD	No disclosure on file
Huaguang Zheng, MD	No disclosure on file
Jacqueline Zummo, MS, MPH, MBA	No disclosure on file
Manpreet Kaur, MD	No disclosure on file
Omar Khan, MD, FAAN	Dr. Khan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Khan has received personal compensation in the range of $100,000-$499,999 for serving as a Director of Epilepsy Center with Veterans Affairs. An immediate family member of Dr. Khan has received personal compensation in the range of $100,000-$499,999 for serving as a Clinical Reviewer with FDA.
Felipe Von Glehn Silva, MD, PhD, MSc, FAAN	Dr. Von Glehn Silva has nothing to disclose.
Jeffrey M. Katz, MD	Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Clement T. Loy, MBBS, BA	No disclosure on file
Binit Shah, MD, FAAN	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Expert Institute.
Soundarya Gowda, MD	Dr. Gowda has nothing to disclose.
David Bearden, MD	Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.
Jessica F. Robb, MD	No disclosure on file
Varina Boerwinkle, MD	Dr. Boerwinkle has nothing to disclose.
Ashkan Mowla, MD, FAAN	No disclosure on file
Paula C. Azevedo, MD	Dr. Azevedo has nothing to disclose.
Massimiliano Copetti	No disclosure on file
Lidia Sarro, MD	No disclosure on file
Mona Shahbazi	No disclosure on file
Jessica Gautreaux, MD, FAAN	Dr. Gautreaux has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Gautreaux has received personal compensation in the range of $500-$4,999 for serving as a educational program development and speaker honoraria with American Headache Society. Dr. Gautreaux has received personal compensation in the range of $0-$499 for serving as a educational program development/speaker with ��ɫ��.
Zurab Nadareishvili, MD, PhD	No disclosure on file
Ping Li, MD	Dr. Li has nothing to disclose.
Meryl A. Butters	No disclosure on file
Vasileios-Arsenios Lioutas, MD	Dr. Lioutas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Qmetis. Dr. Lioutas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mindray. The institution of Dr. Lioutas has received research support from NIH. The institution of Dr. Lioutas has received research support from Alzheimer's Association.
Ramses Ribot, MD	No disclosure on file
Kushak Suchdev, MD	Dr. Suchdev has nothing to disclose.
Yuri Bronstein, MD	Dr. Bronstein has nothing to disclose.
Jade Gehrking	Jade Gehrking has nothing to disclose.
Anthony V. Caparso	No disclosure on file
Dennys Reyes, MD	No disclosure on file
Lori Sheehan, MD	No disclosure on file
Jacob R. Hascalovici, MD	No disclosure on file
Laura Wilson, MD	No disclosure on file
Siddhart K. Mehta, MD	Dr. Mehta has nothing to disclose.
Carolyn Cronin, MD, PhD, FAAN	Dr. Cronin has nothing to disclose.
Luiz H. Castro, MD	Dr. Castro has nothing to disclose.
Lindsey R. Hayes, MD, PhD	No disclosure on file
Nicholas Milano, MD	Dr. Milano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Jackson kelly.
Norma Deri, MD	Norma Deri, MD has nothing to disclose.
Muriel Stoppe	Muriel Stoppe has nothing to disclose.
Jennifer Bain, MD, PhD	Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Bain has received personal compensation in the range of $0-$499 for serving as a Consultant for M3 Consulting. Dr. Bain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Legal Company . Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grin Therapeutics. The institution of Dr. Bain has received research support from Yellow Brick Road Project.
Adarsh Bhimraj, MD	Dr. Bhimraj has nothing to disclose.
Janace Hart	No disclosure on file
Haris Kamal, MD	Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Patricio Millar Vernetti, MD	The institution of Dr. Millar Vernetti has received research support from NIH.
Rajani Sebastian, PhD	No disclosure on file
Jamie J. Van Gompel, MD	Jamie J. Van Gompel, MD has stock in Neuroone.
Jim Wu	No disclosure on file
Neta Zach, PhD	No disclosure on file
Alison L. Walsh, MD	Dr. Walsh has nothing to disclose.
Tritia R. Yamasaki, MD, PhD, FAAN	The institution of Dr. Yamasaki has received research support from Veteran's Affairs. The institution of an immediate family member of Dr. Yamasaki has received research support from Dept of Energy.
Joshua Bonkowsky, MD, PhD	Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bonkowsky has stock in Orchard. The institution of Dr. Bonkowsky has received research support from NIH. The institution of Dr. Bonkowsky has received research support from ELA. An immediate family member of Dr. Bonkowsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care.
Royya F. Modir, MD	Dr. Modir has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medtronic .
Aldo P. Doerner Rinaldi, MD	No disclosure on file
Ahmet Onur Keskin, MD	No disclosure on file
Jessica Chorostecki-Vigrass	No disclosure on file
Ekaterina Bakradze, MD	Dr. Bakradze has nothing to disclose.
Amber G. Ebert, PsyD, DAAN	Dr. Ebert has nothing to disclose.
Daniel Wallman, MD	No disclosure on file
Kim Yen Thi Vu, LMSW	No disclosure on file
Sneha Pandya	No disclosure on file
Zilfah Younus, MD	No disclosure on file
Nasheed I. Jamal, MD, FAAN	Dr. Jamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Jamal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Jamal has received research support from NIH-NIAMS.
Rashmi Rao, MD	Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theranica. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Theranica. Dr. Rao has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Headache Society.
Rachel Ventura, MD	No disclosure on file
Lucia Rivera Lara, MD	Dr. Rivera Lara has received personal compensation in the range of $5,000-$9,999 for serving as a expert witness with Legal firms.
Richard Libman, MD, FAAN	Dr. Libman has nothing to disclose.
Carolyn Schwartz, ScD	No disclosure on file
Gabriel Vidal, MD	Dr. Vidal has nothing to disclose.
Henrikas Vaitkevicius, MD	Dr. Vaitkevicius has received personal compensation for serving as an employee of Noema Pharmaceuticals. Dr. Vaitkevicius has stock in Noema Pharmaceuticals.
Andrew L. Smith, MD	No disclosure on file
Cathleen Adams, DO	No disclosure on file
Robert Arbuckle, MD	No disclosure on file
Chantale O. Branson, MD, MSCR, FAAN	Dr. Branson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Branson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Anita M. Dayal, MD	No disclosure on file
Julia E. Staisch, MD	Dr. Staisch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Staisch has received research support from Michael J Fox.
Shilpa B. Reddy, MD	Dr. Reddy has nothing to disclose.
Karanbir Singh, MD	No disclosure on file
Nancy Wang, MD	The institution of Dr. Wang has received research support from Merck. Dr. Wang has received publishing royalties from a publication relating to health care.
Jan A. Martin, MD	Dr. Martin has nothing to disclose.
NgocHanh H. Vu, MD	Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health.
Hanna Ruider	No disclosure on file
Giovanna Manzano, MD	Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
Firas Kaddouh, MD	Dr. Kaddouh has nothing to disclose.
Hisham Salahuddin, MD	Dr. Salahuddin has nothing to disclose.
Jessie Oldham	No disclosure on file
Aabha Shah, MD	No disclosure on file
Subhash Tummala, MD	No disclosure on file
Harn Shiue, PharmD	Dr. Shiue has nothing to disclose.
Benjamin M. Laitman	No disclosure on file
Lisa Federle	No disclosure on file
Hemant Tiwari	No disclosure on file
Angeline S. Andrew, PhD	No disclosure on file
Achint A. Patel	No disclosure on file
Nelly Campo	No disclosure on file
Venugopalan Y. Vishnu, MD	The institution of Dr. Vishnu has received research support from Department of Health Research.
Gulay Alper, MD	No disclosure on file
David C. McCarthy, Jr., MD	Dr. McCarthy has nothing to disclose.
Kristen M. Upchurch, MD	No disclosure on file
Kristi L. Tucker, MD	No disclosure on file
Lee Goldstein	No disclosure on file
Brandon Holmes, MD, PhD	No disclosure on file
William H. Roth, MD	No disclosure on file
Ethan G. Brown, MD	Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. Dr. Brown has stock in 153 Therapeutics. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Joshua Buck, MD	No disclosure on file
Meghan Candee, MD	Dr. Candee has nothing to disclose.
Peter Z. Yan, MD, MS	Dr. Yan has nothing to disclose.
Mahesh Padmanaban, MD	Dr. Padmanaban has nothing to disclose.
Benjamin A. Jones, MD	Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a expert reviewer with Vaccine Injury Compensation Program.
Alina Rich, MPH	No disclosure on file
Jaskiran Brar, MD	No disclosure on file
Ilana L. Kahn, MD	Dr. Kahn has nothing to disclose.
Nevena Markovic, MD	No disclosure on file
Edgar Olivas, MD	No disclosure on file
Nina M. Massad, MD	Dr. Massad has nothing to disclose.
Syed A. Shah, MD	Dr. Shah has nothing to disclose.
Joshua N. Daniel, MD	No disclosure on file
Eamonn K. Shaikh, MD	No disclosure on file
Hagen Kunte	No disclosure on file
Steven Tversky, DO	No disclosure on file
Mena Samaan, MD	No disclosure on file
Hatim S. Attar, MD	No disclosure on file
Tarun D. Singh, MBBS	Dr. Singh has nothing to disclose.
Manmeet Kaur, MBBS	Dr. Kaur has nothing to disclose.
Abhishek Lunagariya, MD	No disclosure on file
S R. Cooley, MD	No disclosure on file
Jacob C. Rube, MD	Dr. Rube has nothing to disclose.
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Asli Tuncer	No disclosure on file
Pattamon Panyakaew, MD	No disclosure on file
Erin Robertson-Dick	No disclosure on file
Mohammed Elkider, MBBS	No disclosure on file
Daniel Korya, MD	No disclosure on file
Jessica Kiarashi, MD	Dr. Kiarashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for COVE.
Mohammad J. Humayun, MD	Dr. Humayun has nothing to disclose.
AmirHussein Abdolalizadeh	No disclosure on file
Caroline Vloka	No disclosure on file
Shashank Agarwal, MD, MBBS	Dr. Agarwal has nothing to disclose.
Heather Clark	The institution of Heather Clark has received research support from NIH. Heather Clark has received publishing royalties from a publication relating to health care.
Sara DeGregorio	No disclosure on file
Ryan C. Duggan	No disclosure on file
Ling Huang, BS	No disclosure on file
Mariano Marrodan, MD	Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
Haneen Milyani, Jr., MBBS	No disclosure on file
Katerina Placek	No disclosure on file
Harshil Shah, Jr., MBBS	No disclosure on file
Stefan Sillau	Stefan Sillau has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��